{"gene":"SHH","run_date":"2026-06-10T07:46:31","timeline":{"discoveries":[{"year":2002,"finding":"Genetic epistasis in mice showed that Shh and Gli3 are dispensable for limb skeletal element formation; Shh(-/-) Gli3(-/-) double mutants have distally complete but polydactylous limbs lacking normal digit identities. The effects of Shh signaling on skeletal patterning are necessarily mediated through Gli3, by regulating the balance of Gli3 transcriptional activator and repressor activities.","method":"Genetic double-mutant analysis (Shh-/- Gli3-/- mice), skeletal preparation and phenotypic analysis","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic epistasis with rigorous double-mutant analysis, replicated in multiple contexts, foundational mechanistic result","pmids":["12198547"],"is_preprint":false},{"year":1998,"finding":"Shh protein applied ectopically to mandibular mesenchyme induced expression of Ptc and Gli1, demonstrating that SHH can act as a direct inducer of these pathway targets. Ectopic Shh within tooth germs caused abnormal epithelial invagination, indicating a role for Shh in epithelial cell proliferation during tooth development.","method":"Ectopic protein application to explants; in vivo organ culture; mutant analysis (Gli2/Gli3 double mutants)","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — direct protein application assay with target gene readout, replicated in multiple tissue contexts with genetic confirmation","pmids":["9655803"],"is_preprint":false},{"year":2003,"finding":"Using mutant analysis and in vitro explant assays, Gli2 and Gli3 were shown to be required for Shh-dependent sclerotome induction; somitic mesoderm from Gli2(-/-)Gli3(-/-) embryos cannot activate sclerotomal genes in response to exogenous Shh. Additionally, Gli2 was shown to have a repressor function and Gli3 an activator function in the somite, and each Gli preferentially activates a distinct subset of Shh target genes.","method":"Genetic mutant analysis, in vitro explant assays, adenoviral Gli overexpression in presomitic mesoderm explants","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods (genetics, explant culture, gain-of-function), clear mechanistic placement of Gli2 and Gli3 as mediators of Shh sclerotome induction","pmids":["14602680"],"is_preprint":false},{"year":2000,"finding":"Cholesterol is important for SHH biogenesis, and teratogens that induce holoprosencephaly (cyclopamine, cholesterol synthesis inhibitors) affect Shh signal transduction in responding cells rather than Shh biogenesis itself. The structural similarity of the Shh receptor Patched (Ptc) to the Niemann-Pick C1 protein (involved in vesicular cholesterol trafficking) implicates cholesterol in Shh signal transduction.","method":"Pharmacological inhibitor studies (cyclopamine, cholesterol synthesis inhibitors); review of mechanistic data on Shh processing and pathway activation","journal":"Cellular and molecular life sciences : CMLS","confidence":"Medium","confidence_rationale":"Tier 3 / Moderate — mechanistic inference from pharmacological studies and structural homology; single review synthesizing multiple experimental datasets; no direct reconstitution","pmids":["11130177"],"is_preprint":false},{"year":2006,"finding":"FGF9 and SHH signaling coordinate lung mesenchymal development through distinct sub-mesothelial and sub-epithelial compartments. FGF9 signals from the epithelium to sub-epithelial mesenchyme to maintain SHH signaling, which regulates cell proliferation, survival and mesenchymal-to-epithelial signaling. FGF9 alone can only partially rescue vascular defects caused by SHH loss, and SHH cannot rescue FGF9-null vascular phenotypes, indicating they regulate distinct aspects of development.","method":"Loss-of-function and inducible gain-of-function mouse models (Fgf9 KO, Shh signaling loss), phenotypic and gene expression analysis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — reciprocal gain/loss of function genetics, two independent mouse models, clear pathway epistasis with defined cellular phenotypes","pmids":["16540513"],"is_preprint":false},{"year":2007,"finding":"FGF9 and SHH signaling to lung mesenchyme (but not to endothelial cells) are each necessary and together sufficient for distal pulmonary capillary development, acting by regulating Vegfa expression in lung mesenchyme. VEGF signaling is required downstream of FGF9-mediated blood vessel formation.","method":"Gain- and loss-of-function genetics in mice, conditional deletion, Vegfa expression analysis, vascular morphometry","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Strong — dual gain/loss of function mouse models with clear cellular phenotype readout, pathway epistasis established","pmids":["17881491"],"is_preprint":false},{"year":2009,"finding":"BMP activity negatively regulates Shh transcription in the limb bud, forming a BMP-Shh negative-feedback loop that confines Shh expression to the ZPA. BMP-dependent downregulation of Shh is achieved by interfering with FGF and Wnt signaling activities that maintain Shh expression. FGF induction of Shh requires protein synthesis and is mediated by the ERK1/2 MAPK pathway.","method":"In vivo limb bud manipulation, pharmacological inhibitors (ERK1/2 MAPK), gene expression analysis, gain- and loss-of-function experiments","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal approaches (genetics, pharmacology, expression), single lab, mechanistic dissection of feedback loop","pmids":["19855020"],"is_preprint":false},{"year":2011,"finding":"Lhx6 and Lhx8 transcription factors coexpressed in early-born MGE neurons are required to induce neuronal Shh expression. Shh function in early-born MGE neurons feeds forward to promote SHH signaling in the overlying progenitor zone, regulating Lhx6, Lhx8, and Nkx2-1 expression and production of late-born somatostatin+ and parvalbumin+ cortical interneurons.","method":"Genetic conditional deletion of Shh in MGE mantle zone, gene expression analysis, interneuron counting","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 2 / Moderate — clean genetic conditional KO with defined cellular phenotype and molecular pathway placement, single lab with multiple readouts","pmids":["21658586"],"is_preprint":false},{"year":2010,"finding":"Foxa2 positively regulates Shh expression in multiple tissues, but in the midbrain Foxa1 and Foxa2 attenuate Shh signaling by directly inhibiting expression of its intracellular transducer Gli2 at the transcriptional level. ChIP experiments showed that Foxa2 binds to genomic regions of Gli2.","method":"Conditional KO of Foxa2 in midbrain (Wnt1cre;Foxa2flox/flox), gain-of-function studies in mice, chromatin immunoprecipitation (ChIP)","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic loss/gain of function plus direct ChIP binding evidence, single lab, two orthogonal methods","pmids":["21093585"],"is_preprint":false},{"year":2015,"finding":"The Shh gradient amplitude in the mouse neural tube increases over time, but Gli transcriptional effector activity initially increases then decreases (adaptation). Computational and experimental analysis identified three contributing mechanisms: transcriptional upregulation of inhibitory receptor Ptch1, transcriptional downregulation of Gli, and differential stability of active vs. inactive Gli isoforms. Gli2 protein expression is downregulated during neural tube patterning, and adaptation continues when the pathway is stimulated downstream of Ptch1.","method":"Quantitative imaging of Shh gradient in developing mouse neural tube, computational modeling, Gli2 protein expression analysis, NIH3T3 cell culture experiments","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 / Moderate — quantitative in vivo gradient measurements combined with computational modeling and cell culture validation, multiple orthogonal approaches, single lab","pmids":["25833741"],"is_preprint":false},{"year":2014,"finding":"Ptch2 mediates the Shh response in Ptch1-/- cells. The Shh response in Ptch1(-/-) cells is ligand-dependent and can be inhibited by Shh-blocking antibody 5E1. Ptch1(-/-);Ptch2(-/-) double KO cells cannot further activate the Shh response, demonstrating that Ptch2 mediates Shh signaling in the absence of Ptch1. Expression of dominant-negative Ptch2 in developing chick neural tube caused activation of the Shh response, indicating Ptch2 suppresses Shh signaling at early developmental stages.","method":"Ptch1/Ptch2 double KO cells, Shh-blocking antibody (5E1), dominant-negative Ptch constructs in chick neural tube electroporation, cell migration assays","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic double KO combined with antibody blocking and dominant-negative approaches, multiple orthogonal methods, single lab","pmids":["25085974"],"is_preprint":false},{"year":2014,"finding":"Shh-induced activation of Smoothened (Smo) drastically increases Hhip (Hedgehog-interacting protein) internalization and degradation cell-autonomously. While Hhip can leave its site of synthesis to inhibit Shh non-cell-autonomously, it cannot cell-autonomously inhibit the consequences of Smo activation. This provides a mechanism by which Shh activates pathway response while negating cell-autonomous effects of Hhip, yet Hhip retains non-cell-autonomous inhibitory capacity.","method":"Hhip overexpression and localization assays, Smo activation studies, internalization and degradation assays","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — direct cell biological assays of Hhip internalization upon Smo activation, single lab, multiple orthogonal readouts","pmids":["25215859"],"is_preprint":false},{"year":2014,"finding":"Boc (a Shh-binding protein) associates with the Shh receptor Ptch1 to mediate Shh signaling. Boc, through elevated Shh signaling, promotes high levels of DNA damage mediated by CyclinD1. High DNA damage in the presence of Boc increases the incidence of Ptch1 loss of heterozygosity, driving progression from early to advanced medulloblastoma.","method":"Boc genetic inactivation in mice, medulloblastoma progression analysis, CyclinD1 mechanistic studies, DNA damage assays","journal":"Developmental cell","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO in mouse tumor model with defined molecular mechanism (CyclinD1-mediated DNA damage), single lab","pmids":["25263791"],"is_preprint":false},{"year":2015,"finding":"Eya1 phosphatase, acting together with the DNA-binding protein Six1, promotes gene induction in response to Shh by regulating Gli transcriptional activators. Eya1 was identified via shRNA screen of the phosphatome and is required for Shh-dependent hindbrain growth; catalytically active Eya1 (its phosphatase activity) is necessary for this function.","method":"shRNA screen of phosphatome, loss-of-function and gain-of-function assays, catalytic mutant analysis, in vivo genetic analysis of hindbrain development","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — unbiased screen plus mechanistic follow-up with catalytic mutagenesis and in vivo validation, multiple orthogonal methods, single lab","pmids":["25816987"],"is_preprint":false},{"year":2018,"finding":"Shh-mediated axon guidance of commissural neurons requires Dock3/4 GEFs and their binding partners ELMO1/2. Mechanistically, Dock and ELMO interact with Boc (the Shh receptor), and this interaction is reduced upon Shh stimulation. Shh stimulation translocates ELMO to the growth cone periphery and activates Rac1, identifying Dock/ELMO as an effector complex of non-canonical Shh signaling for growth cone turning.","method":"shRNA knockdown in vitro axon turning assays, in vivo commissural axon guidance analysis, co-immunoprecipitation of Dock/ELMO with Boc, Rac1 activation assays, subcellular localization imaging","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 / Moderate — Co-IP binding partner identification, in vitro and in vivo KD with specific axon guidance phenotype, Rac1 activation assay, single lab with multiple orthogonal methods","pmids":["30078728"],"is_preprint":false},{"year":2007,"finding":"Protease nexin 1 (PN-1/SERPINE2) interacts with LRP (low-density lipoprotein receptor-related proteins) to antagonize SHH-induced CGNP proliferation and inhibit GLI1 transcriptional activity. PN-1 binding to LRPs interferes with SHH-induced cyclin D1 expression. CGNPs from Pn-1-deficient mice show enhanced basal proliferation due to overactivation of the SHH pathway.","method":"PN-1 knockout mouse analysis, proliferation assays, GLI1 activity assays, cyclin D1 expression analysis, binding studies with LRP","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with defined molecular mechanism (LRP interaction, cyclin D1), multiple readouts, single lab","pmids":["17409116"],"is_preprint":false},{"year":2019,"finding":"Highly recurrent U1 snRNA hotspot mutations (r.3A>G) in ~50% of SHH medulloblastomas occur in the 5' splice-site binding region and cause disrupted RNA splicing with excess 5' cryptic splicing events. Mutant U1 snRNA-mediated alternative splicing inactivates tumor-suppressor PTCH1 and activates oncogenes GLI2 and CCND2, identifying a non-canonical mechanism of SHH pathway activation.","method":"Whole-genome/transcriptome sequencing of 250 SHH medulloblastomas, splicing analysis, functional characterization of U1 snRNA mutations","journal":"Nature","confidence":"High","confidence_rationale":"Tier 2 / Strong — large cohort sequencing with functional splicing validation, mechanistically links U1 snRNA mutation to SHH pathway activation, independently strong evidence","pmids":["31664194"],"is_preprint":false},{"year":2016,"finding":"In developing hair buds, SHH signaling is differentially distributed between asymmetric daughter cells: displaced WNT-low suprabasal daughters become stem cells that respond to paracrine SHH and symmetrically expand, while basal daughters express but do not respond to SHH. This WNT-SHH antagonism specifies and expands stem cells prior to niche formation.","method":"Live imaging, immunofluorescence, genetics, cell-cycle analyses, in utero lentiviral transduction, lineage tracing","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple orthogonal methods including live imaging, lineage tracing and genetics in single study, clear mechanistic link between SHH/WNT pathway distribution and cell fate","pmids":["26771489"],"is_preprint":false},{"year":2021,"finding":"YAP transcription activity, activated downstream of GNAS loss, directly drives Shh expression. Secreted SHH in turn induces YAP activation, Shh expression, and osteoblast differentiation in surrounding wild-type cells, forming a self-amplifying YAP-SHH loop that is necessary and sufficient for heterotopic ossification expansion. Genetic or pharmacological inhibition of either YAP or SHH abolished HO.","method":"Mouse models of POH (Gnas KO) and FOP, genetic ablation and pharmacological inhibition of YAP and SHH, gain-of-function experiments, gene expression analysis","journal":"Science translational medicine","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple disease mouse models, genetic and pharmacological inhibition of both nodes, demonstration of both necessity and sufficiency, single lab with multiple orthogonal approaches","pmids":["34162750"],"is_preprint":false},{"year":2022,"finding":"O-GlcNAc transferase (OGT) regulates granule neuron precursor neurogenesis by activating the Shh signaling pathway via O-GlcNAcylation at S355 of Gli2. This modification promotes Gli2 deacetylation and transcriptional activity through dissociation from p300 (a histone acetyltransferase). OGT inhibition improves survival in a medulloblastoma mouse model.","method":"OGT conditional KO, O-GlcNAcylation site mapping (S355 of Gli2), Gli2-p300 co-immunoprecipitation, acetylation/deacetylation assays, medulloblastoma mouse model","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — PTM site identification (S355), biochemical dissection of Gli2-p300 interaction, genetic KO in vivo, multiple orthogonal methods, single lab","pmids":["35969743"],"is_preprint":false},{"year":2022,"finding":"Wnt signaling directly regulates epithelial expression of Sonic Hedgehog (SHH), which in turn acts on mesenchymal cells to drive villi formation during small intestine morphogenesis. Subepithelial mesenchymal cell gradients supporting Wnt signaling regulate epithelial SHH expression as part of a mesenchymal-epithelial crosstalk.","method":"Single-cell analysis, in vitro organoid culture, genetic manipulation, in situ hybridization, gene expression analysis","journal":"Nature communications","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — mechanistic pathway placement with genetic and functional experiments, single lab, multiple readouts","pmids":["35132078"],"is_preprint":false},{"year":2019,"finding":"A prechordal enhancer (SBE7) was identified that directs Shh expression in both the prechordal plate and ventral midline of the forebrain. Deletion of SBE7 from the mouse genome markedly downregulated Shh in the rostral axial mesoderm and ventral forebrain/hypothalamus, causing craniofacial abnormality resembling human holoprosencephaly. Prechordal SHH signaling triggers secondary Shh induction in the forebrain, which then directs neuronal differentiation.","method":"Enhancer identification, targeted deletion from mouse genome, in vivo reporter assays, gene expression analysis","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Moderate — targeted genome deletion with defined in vivo phenotype and two-step signaling cascade, single lab, multiple readouts","pmids":["31685615"],"is_preprint":false},{"year":2019,"finding":"Abrogating constitutive transcription over the ZRS enhancer shifts Shh-ZRS contacts and moderately reduces Shh transcription. Deletion of CTCF binding sites around the ZRS results in loss of the preformed Shh-ZRS interaction and 50% decrease in Shh expression but no detectable phenotype, indicating an additional CTCF-independent mechanism. Combining CTCF binding site loss with a hypomorphic ZRS allele causes severe Shh loss of function and digit agenesis.","method":"CTCF binding site deletion, hypomorphic ZRS allele, chromosome conformation capture, in vivo mouse genetics","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 / Strong — multiple independent genetic deletions in mice with 3D chromatin conformation analysis, clear mechanistic dissection of enhancer-promoter communication, single lab with multiple orthogonal methods","pmids":["31147463"],"is_preprint":false},{"year":2016,"finding":"Foxf2 (downstream of Shh signaling) is required in neural crest-derived palatal mesenchyme for palatogenesis; Foxf1 and Foxf2 together repress Fgf18 expression in the mesenchyme, which is necessary to maintain Shh expression in the palatal epithelium. Addition of exogenous Fgf18 protein to cultured palatal explants directly inhibited Shh expression, establishing a Shh-Foxf-Fgf18-Shh molecular circuit.","method":"Cre/loxP tissue-specific conditional KO, RNA-seq, whole-mount in situ hybridization, palatal explant culture with exogenous FGF18 protein","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 / Moderate — conditional genetics combined with direct protein treatment of explants, multiple orthogonal methods, single lab","pmids":["26745863"],"is_preprint":false},{"year":2023,"finding":"YAP, acting as a mechanosensor, is activated by a gradient of mechanical stress and tissue stiffness in the notochord and ventral neural tube. YAP activation induces FoxA2 and Shh expression; Hedgehog signaling activation rescues neural tube patterning defects caused by Yap deficiency (but not notochord formation), establishing that mechanotransduction via Yap acts in a feedforward mechanism to activate Shh expression for floor plate induction.","method":"Yap conditional KO mice, gain-of-function experiments, mechanical stress measurement, tissue stiffness analysis, Hedgehog signaling rescue experiments","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic KO with rescue experiments, mechanistic dissection of upstream regulator of Shh expression, single lab, multiple readouts","pmids":["37315133"],"is_preprint":false},{"year":2022,"finding":"ETV2 acts as a pioneer transcription factor that initiates Shh expression by changing chromatin status at the ZRS limb enhancer. Etv2 expression precedes Shh in limb buds; Etv2 inactivation prevents ZRS chromatin opening and abolishes Shh expression. Etv2 overexpression causes nucleosomal displacement at ZRS, ectopic Shh expression, and polydactyly. ETV2 is also antagonized by ETV4/5 repressors, and known human polydactyl mutations introduce novel ETV2 binding sites in ZRS.","method":"Etv2 conditional KO, gain-of-function overexpression, ATAC-seq chromatin accessibility, nucleosome displacement assays, luciferase reporter assays for ETV2 binding sites","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1-2 / Strong — chromatin accessibility (ATAC-seq) plus genetic gain/loss of function and mechanistic mutagenesis of ETS binding sites, multiple orthogonal methods, single lab","pmids":["35864091"],"is_preprint":false},{"year":2013,"finding":"Notochord/floor plate-derived Shh regulates mesonephric tubule number and position through indirect effects on the paraxial mesoderm (rather than direct regulation). Mesonephros-specific Shh ablation showed that locally-expressed Shh is not required for mesonephric development. Stage-specific ablation and lineage analysis demonstrated that midline-derived Shh regulates nephrogenic gene expression indirectly via the paraxial mesoderm.","method":"Shh conditional KO (Hoxb7-Cre, Sall1CreERT2, ShhCreERT2), stage-specific ablation, lineage analysis of Hh-responsive cells, gene expression analysis","journal":"Developmental biology","confidence":"High","confidence_rationale":"Tier 2 / Moderate — multiple conditional KO models with stage-specific ablation, clear mechanistic dissection of source vs. target tissue, single lab","pmids":["24370450"],"is_preprint":false},{"year":2020,"finding":"SHH binding to PTCH not only activates the canonical pathway but also blocks PTCH-induced apoptosis (PTCH functions as a dependence receptor that triggers apoptosis in the absence of SHH). Autocrine SHH interference in colon, pancreatic, and lung cancer cell lines triggered cell death through PTCH proapoptotic signaling without changing canonical pathway activity. In vivo, SHH interference decreased primary tumor growth and metastasis.","method":"SHH interference (knockdown/blocking) in cancer cell lines, in vivo xenograft models, apoptosis assays, canonical pathway activity measurement","journal":"Cancer research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vitro and in vivo loss-of-function with defined apoptotic mechanism, single lab, multiple cancer cell line models","pmids":["32060146"],"is_preprint":false},{"year":2020,"finding":"Downregulation of Shh signaling in the hair matrix is a critical early event in chemotherapy-induced alopecia (CIA). Inhibition of Shh signaling recapitulated key morphological features of CIA, and recombinant Shh protein partially rescued hair loss. Phosphoproteomics identified MAPK pathway activation as a key upstream event that controls Shh downregulation. Shh signaling is an evolutionarily conserved target in CIA pathobiology.","method":"Mouse model of CIA, recombinant Shh protein rescue, Shh signaling inhibition, phosphoproteomics, human hair follicle organ culture","journal":"The Journal of investigative dermatology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — in vivo mouse model, protein rescue, phosphoproteomics for pathway placement, human follicle validation; single lab","pmids":["32682910"],"is_preprint":false},{"year":2020,"finding":"In developing zebrafish tuberal/anterior hypothalamus, Shh acts as an on-off switch for the homeodomain transcription factor Rx3. Shh coordinates progenitor cell selection and behavior in the tuberal/anterior hypothalamus; in absence of Shh, the shh+ anterior recess does not form and resident differentiated cell types fail to develop.","method":"rx3 chk mutant/morphant zebrafish, Shh signaling manipulation, EdU pulse-chase, gene expression analysis","journal":"Development (Cambridge, England)","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic mutant and morpholino studies with pathway manipulation, defined cellular phenotype, single lab","pmids":["27317806"],"is_preprint":false},{"year":2019,"finding":"Genomic analysis mapped Shh-responsive genes in the otic vesicle using Smo loss-of-function and Shh gain-of-function mouse mutants. Gli2 ChIP-seq combined with ATAC-seq identified inner ear enhancers near Shh-responsive genes, revealing Shh-dependent transcriptional networks controlling cochlear duct morphogenesis.","method":"Comparative transcriptomics of Smo KO and Shh gain-of-function mutants, ATAC-seq, Gli2 ChIP-seq","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1-2 / Moderate — ChIP-seq and ATAC-seq plus genetic gain/loss of function, multiple orthogonal genomic methods, single lab","pmids":["31488567"],"is_preprint":false}],"current_model":"SHH is a secreted morphogen that signals through binding to its receptor PTCH1 (and co-receptors BOC, GAS1, CDON), relieving PTCH1-mediated inhibition of Smoothened (SMO) to activate GLI transcription factors; its transcription is initiated by pioneer factors such as ETV2 acting on the ZRS enhancer and reinforced by mechanotransduction through YAP/FoxA2, while downstream signaling dynamics are shaped by negative feedback through PTCH1 upregulation and Gli protein stability, and by post-translational modifications including O-GlcNAcylation of GLI2 at S355 that modulates its transcriptional activity; non-canonically, SHH also guides axon growth cones through Boc-Dock/ELMO-Rac1 signaling, blocks PTCH1-induced apoptosis as a survival signal, and forms positive feedback loops (e.g., YAP-SHH in heterotopic ossification) with its effects on target tissues mediated through distinct Gli protein combinations."},"narrative":{"mechanistic_narrative":"SHH is a secreted morphogen that patterns diverse developing tissues by activating the Hedgehog pathway in responding cells, where its effects are transduced through GLI transcription factors that integrate distinct activator and repressor activities [PMID:12198547, PMID:14602680]. Applied ectopically, SHH directly induces the pathway targets Ptch and Gli1 and drives epithelial proliferation [PMID:9655803], and the cellular outcome depends on the GLI repertoire: GLI2 and GLI3 are required to translate the SHH signal into target-gene induction (e.g., sclerotome specification), with each GLI preferentially activating a distinct subset of targets [PMID:12198547, PMID:14602680]. SHH signals through the receptor PTCH1, and PTCH2 provides redundant ligand-dependent reception in the absence of PTCH1 [PMID:25085974]; the co-receptor BOC associates with PTCH1 to potentiate signaling [PMID:25263791]. Pathway output is shaped by multiple feedback and modulatory inputs—transcriptional upregulation of the inhibitory receptor Ptch1, downregulation of Gli, and differential GLI isoform stability produce signal adaptation over time [PMID:25833741]; Smo activation drives cell-autonomous internalization and degradation of the antagonist HHIP while preserving HHIP's non-cell-autonomous inhibition [PMID:25215859]; and GLI activity is tuned by the EYA1/SIX1 phosphatase module [PMID:25816987] and by O-GlcNAcylation of GLI2 at S355, which promotes GLI2 deacetylation and dissociation from p300 to enhance transcription [PMID:35969743]. SHH transcription is itself the focus of intricate control: pioneer factor ETV2 opens chromatin at the limb ZRS enhancer to initiate expression [PMID:35864091], CTCF-dependent enhancer–promoter looping and constitutive transcription sustain ZRS output [PMID:31147463], a prechordal enhancer (SBE7) directs forebrain/ventral midline expression whose loss models holoprosencephaly [PMID:31685615], and mechanotransduction through YAP→FoxA2 feeds forward to activate Shh for floor plate induction [PMID:37315133]. Across tissues SHH operates within reciprocal signaling circuits—with FGF9 in lung mesenchyme and vasculature [PMID:16540513, PMID:17881491], BMP/FGF/WNT in the limb and intestine [PMID:19855020, PMID:35132078], and FOXF–FGF18 in the palate [PMID:26745863]. Non-canonically, SHH guides commissural axons by acting through BOC and a DOCK/ELMO–Rac1 effector complex at the growth cone [PMID:30078728], and acts as a survival signal by blocking PTCH-induced apoptosis when PTCH behaves as a dependence receptor [PMID:32060146]. Dysregulated SHH signaling drives disease: recurrent U1 snRNA hotspot mutations activate the pathway in SHH medulloblastoma by mis-splicing PTCH1, GLI2, and CCND2 [PMID:31664194], BOC-dependent DNA damage promotes medulloblastoma progression [PMID:25263791], and a self-amplifying YAP–SHH loop drives heterotopic ossification [PMID:34162750].","teleology":[{"year":1998,"claim":"Established that SHH protein directly induces canonical pathway targets and drives epithelial proliferation, defining its readouts in responding tissue.","evidence":"Ectopic Shh protein application to mandibular/tooth explants with Ptc and Gli1 readout, plus Gli2/Gli3 mutant analysis","pmids":["9655803"],"confidence":"High","gaps":["Did not resolve receptor-level mechanism of induction","Direct vs. relayed induction within the tissue not fully separated"]},{"year":2000,"claim":"Distinguished SHH biogenesis from signal transduction, placing cholesterol-dependent steps in the receiving cell and linking PTCH function to cholesterol trafficking.","evidence":"Pharmacological inhibitor studies (cyclopamine, cholesterol synthesis inhibitors) and structural homology review of Patched to NPC1","pmids":["11130177"],"confidence":"Medium","gaps":["No direct reconstitution of cholesterol handling by PTCH","Synthesis from heterogeneous datasets, not a single experiment"]},{"year":2002,"claim":"Resolved that SHH patterning of the limb skeleton is mediated entirely through GLI3 by setting the activator/repressor balance, rather than by SHH acting independently.","evidence":"Shh-/- Gli3-/- double-mutant mouse genetic epistasis with skeletal phenotyping","pmids":["12198547"],"confidence":"High","gaps":["Did not address GLI2 contribution in limb","Molecular control of activator/repressor ratio not defined"]},{"year":2003,"claim":"Assigned division of labor among GLI proteins, showing GLI2 and GLI3 are jointly required for SHH-dependent sclerotome induction and each activates distinct target subsets.","evidence":"Gli2-/-Gli3-/- mouse genetics, explant assays, adenoviral Gli overexpression in presomitic mesoderm","pmids":["14602680"],"confidence":"High","gaps":["Target-specificity determinants not identified","Tissue generality of GLI labor division untested"]},{"year":2006,"claim":"Defined reciprocal FGF9–SHH crosstalk in lung mesenchyme, showing each pathway controls distinct, non-substitutable aspects of development.","evidence":"Reciprocal gain/loss-of-function mouse models with phenotypic and gene-expression analysis","pmids":["16540513"],"confidence":"High","gaps":["Direct molecular intermediaries between FGF9 and SHH not fully mapped"]},{"year":2007,"claim":"Showed SHH and FGF9 converge on mesenchymal Vegfa to drive distal pulmonary capillary formation, placing SHH upstream of a defined vascular effector.","evidence":"Conditional gain/loss-of-function mouse genetics, Vegfa expression and vascular morphometry","pmids":["17881491"],"confidence":"High","gaps":["GLI-level regulation of Vegfa not directly shown"]},{"year":2007,"claim":"Identified PN-1/SERPINE2–LRP as an extrinsic brake on SHH-induced proliferation, acting via GLI1 and cyclin D1.","evidence":"Pn-1 knockout mouse CGNP proliferation assays, GLI1 activity and cyclin D1 readouts, LRP binding studies","pmids":["17409116"],"confidence":"High","gaps":["Biochemical mechanism of LRP-mediated GLI1 inhibition incomplete"]},{"year":2009,"claim":"Dissected upstream transcriptional control of Shh in the limb, defining a BMP–Shh negative-feedback loop and FGF/ERK-dependent maintenance.","evidence":"In vivo limb manipulation, ERK1/2 inhibitors, gain/loss-of-function expression analysis","pmids":["19855020"],"confidence":"High","gaps":["Direct transcription factors mediating BMP repression at Shh not identified"]},{"year":2010,"claim":"Revealed FOXA2 as a context-dependent regulator that activates Shh in some tissues but directly represses its transducer Gli2 in midbrain.","evidence":"Wnt1cre;Foxa2 conditional KO, gain-of-function, and ChIP of FOXA2 on Gli2 loci","pmids":["21093585"],"confidence":"High","gaps":["Determinants of activator vs. repressor context not defined"]},{"year":2011,"claim":"Placed SHH within a feed-forward neurogenic circuit, showing LHX6/LHX8 induce neuronal Shh that sustains progenitor-zone signaling for interneuron production.","evidence":"Conditional Shh deletion in MGE mantle zone, expression analysis, interneuron counting","pmids":["21658586"],"confidence":"High","gaps":["Direct LHX-to-Shh transcriptional link not biochemically resolved"]},{"year":2013,"claim":"Distinguished SHH source from target, showing midline-derived SHH patterns mesonephric tubules indirectly via paraxial mesoderm.","evidence":"Multiple conditional Shh KO models, stage-specific ablation, lineage analysis","pmids":["24370450"],"confidence":"High","gaps":["Intermediate paraxial signal relaying SHH effect not identified"]},{"year":2014,"claim":"Demonstrated receptor redundancy, showing PTCH2 mediates ligand-dependent SHH reception when PTCH1 is absent and normally suppresses signaling.","evidence":"Ptch1/Ptch2 double-KO cells, 5E1 blocking antibody, dominant-negative Ptch2 in chick neural tube","pmids":["25085974"],"confidence":"High","gaps":["Quantitative contribution of PTCH2 in normal development unclear"]},{"year":2014,"claim":"Explained how cells reconcile signaling with the antagonist HHIP, showing Smo activation drives cell-autonomous HHIP degradation while sparing its paracrine inhibition.","evidence":"HHIP overexpression/localization, Smo activation, internalization and degradation assays","pmids":["25215859"],"confidence":"Medium","gaps":["Machinery routing HHIP to degradation not identified","Single-lab cell-biological observation"]},{"year":2014,"claim":"Linked the co-receptor BOC to oncogenic SHH output, showing BOC potentiates signaling and drives CyclinD1-mediated DNA damage promoting medulloblastoma progression.","evidence":"Boc genetic inactivation in mouse medulloblastoma model, CyclinD1 and DNA-damage assays","pmids":["25263791"],"confidence":"Medium","gaps":["Mechanism connecting elevated SHH signaling to DNA damage incomplete","Generality beyond this tumor model untested"]},{"year":2015,"claim":"Defined the dynamic logic of SHH interpretation, showing GLI activity adapts via Ptch1 upregulation, Gli downregulation, and differential GLI isoform stability.","evidence":"Quantitative gradient imaging in mouse neural tube, computational modeling, NIH3T3 validation","pmids":["25833741"],"confidence":"High","gaps":["Molecular basis of differential GLI isoform stability not resolved"]},{"year":2015,"claim":"Identified EYA1/SIX1 phosphatase activity as a positive regulator of GLI activators required for SHH-dependent hindbrain growth.","evidence":"Phosphatome shRNA screen, catalytic mutant analysis, in vivo genetics","pmids":["25816987"],"confidence":"High","gaps":["Direct GLI dephosphorylation substrate not demonstrated"]},{"year":2016,"claim":"Established a Shh-Foxf-Fgf18-Shh circuit in palate, showing FOXF repression of mesenchymal Fgf18 sustains epithelial Shh.","evidence":"Tissue-specific conditional KO, RNA-seq, in situ hybridization, FGF18 protein on explants","pmids":["26745863"],"confidence":"High","gaps":["Direct FGF18 repression mechanism on Shh promoter not shown"]},{"year":2016,"claim":"Showed WNT-SHH antagonism asymmetrically distributes SHH responsiveness between daughter cells to specify and expand hair follicle stem cells.","evidence":"Live imaging, lineage tracing, genetics, cell-cycle analysis in hair buds","pmids":["26771489"],"confidence":"High","gaps":["Molecular basis of differential SHH responsiveness between daughters unclear"]},{"year":2016,"claim":"Identified SHH as a binary switch controlling Rx3 and progenitor behavior in zebrafish tuberal/anterior hypothalamus.","evidence":"rx3 mutant/morphant zebrafish, SHH manipulation, EdU pulse-chase","pmids":["27317806"],"confidence":"Medium","gaps":["Mechanism of switch-like Rx3 regulation not defined","Morpholino-based loss of function"]},{"year":2018,"claim":"Defined a non-canonical SHH axon-guidance effector pathway operating through BOC and DOCK/ELMO to activate Rac1 at the growth cone.","evidence":"shRNA axon-turning assays, in vivo guidance, BOC Co-IP, Rac1 activation, growth-cone imaging","pmids":["30078728"],"confidence":"High","gaps":["How SHH binding reduces BOC-DOCK/ELMO association mechanistically unresolved"]},{"year":2019,"claim":"Identified U1 snRNA hotspot mutations as a non-canonical driver of SHH medulloblastoma, mis-splicing PTCH1, GLI2, and CCND2.","evidence":"Whole-genome/transcriptome sequencing of 250 tumors with functional splicing characterization","pmids":["31664194"],"confidence":"High","gaps":["How a single splicing change coordinately rewires multiple pathway genes not fully mechanized"]},{"year":2019,"claim":"Defined enhancer-promoter architecture controlling Shh, showing CTCF-dependent ZRS looping and constitutive transcription jointly sustain expression.","evidence":"CTCF site and hypomorphic ZRS deletions, chromosome conformation capture, mouse genetics","pmids":["31147463"],"confidence":"High","gaps":["Nature of the CTCF-independent maintenance mechanism unidentified"]},{"year":2019,"claim":"Identified the prechordal enhancer SBE7 directing forebrain/ventral-midline Shh, whose deletion models holoprosencephaly via a two-step signaling cascade.","evidence":"Targeted enhancer deletion, reporter assays, expression analysis in mice","pmids":["31685615"],"confidence":"High","gaps":["Trans-acting factors binding SBE7 not identified"]},{"year":2019,"claim":"Mapped SHH-responsive transcriptional networks in the otic vesicle, linking GLI2 occupancy to inner-ear enhancers controlling cochlear morphogenesis.","evidence":"Smo KO vs. Shh gain-of-function transcriptomics, ATAC-seq, Gli2 ChIP-seq","pmids":["31488567"],"confidence":"High","gaps":["Functional validation of individual identified enhancers limited"]},{"year":2020,"claim":"Revealed a survival function of SHH independent of canonical signaling, blocking PTCH dependence-receptor apoptosis in cancer cells.","evidence":"SHH interference in colon/pancreatic/lung lines, xenografts, apoptosis and canonical-activity assays","pmids":["32060146"],"confidence":"Medium","gaps":["PTCH proapoptotic effector machinery not defined","Single-lab cell-line and xenograft scope"]},{"year":2020,"claim":"Placed SHH downregulation as an early causal event in chemotherapy-induced alopecia, downstream of MAPK activation.","evidence":"Mouse CIA model, recombinant SHH rescue, phosphoproteomics, human follicle organ culture","pmids":["32682910"],"confidence":"Medium","gaps":["Direct MAPK-to-Shh transcriptional link not established","Single lab"]},{"year":2021,"claim":"Defined a self-amplifying YAP–SHH loop downstream of GNAS loss that is necessary and sufficient for heterotopic ossification.","evidence":"POH/FOP mouse models, genetic and pharmacological YAP/SHH inhibition, gain-of-function","pmids":["34162750"],"confidence":"High","gaps":["Direct YAP binding at Shh regulatory regions not shown in this context"]},{"year":2022,"claim":"Identified ETV2 as a pioneer factor that opens ZRS chromatin to initiate Shh expression, with ETV4/5 antagonism and disease-relevant binding-site gains.","evidence":"Etv2 conditional KO/overexpression, ATAC-seq, nucleosome displacement, ETS-site reporter assays","pmids":["35864091"],"confidence":"High","gaps":["How ETV2 pioneering hands off to sustained ZRS transcription not resolved"]},{"year":2022,"claim":"Established WNT-to-epithelial-Shh-to-mesenchyme signaling driving intestinal villus formation.","evidence":"Single-cell analysis, organoid culture, genetics, in situ hybridization","pmids":["35132078"],"confidence":"Medium","gaps":["Direct WNT regulation of the Shh promoter not demonstrated","Single lab"]},{"year":2022,"claim":"Defined O-GlcNAcylation of GLI2 at S355 as a post-translational switch enhancing GLI2 transcription via deacetylation and p300 dissociation.","evidence":"OGT conditional KO, S355 site mapping, Gli2-p300 Co-IP, acetylation assays, medulloblastoma model","pmids":["35969743"],"confidence":"High","gaps":["How S355 O-GlcNAcylation mechanistically drives deacetylation not fully resolved"]},{"year":2023,"claim":"Identified mechanotransduction as an upstream activator of Shh, showing YAP responds to tissue stiffness to induce FoxA2 and Shh for floor plate induction.","evidence":"Yap conditional KO with rescue, mechanical stress/stiffness measurement, Hedgehog rescue","pmids":["37315133"],"confidence":"High","gaps":["Direct molecular link from YAP to Shh transcription in neural tube not shown"]},{"year":null,"claim":"How the diverse upstream enhancer inputs (ETV2, CTCF looping, YAP/FoxA2, WNT, BMP/FGF) are integrated at the SHH locus to produce tissue-specific expression, and how PTCH dependence-receptor apoptosis is executed at the molecular level, remain open.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No unified model of SHH locus regulation across tissues","PTCH proapoptotic effector pathway undefined","Structural basis of SHH–PTCH1/PTCH2/BOC receptor engagement not addressed in the corpus"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0048018","term_label":"receptor ligand activity","supporting_discovery_ids":[1,10,12]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[1,10,14]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[1,11,28]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,10,9]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[4,5,7,17,21,24,25]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[16,18,27,12]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[22,24,25,30]}],"complexes":[],"partners":["PTCH1","PTCH2","BOC","HHIP","GLI2","GLI3","GLI1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q15465","full_name":"Sonic hedgehog protein","aliases":["HHG-1","Shh unprocessed N-terminal signaling and C-terminal autoprocessing domains","ShhNC"],"length_aa":462,"mass_kda":49.6,"function":"The C-terminal part of the sonic hedgehog protein precursor displays an autoproteolysis and a cholesterol transferase activity (By similarity). Both activities result in the cleavage of the full-length protein into two parts (ShhN and ShhC) followed by the covalent attachment of a cholesterol moiety to the C-terminal of the newly generated ShhN (By similarity). Both activities occur in the endoplasmic reticulum (By similarity). Once cleaved, ShhC is degraded in the endoplasmic reticulum (By similarity) The dually lipidated sonic hedgehog protein N-product (ShhNp) is a morphogen which is essential for a variety of patterning events during development. Induces ventral cell fate in the neural tube and somites (PubMed:24863049). Involved in the patterning of the anterior-posterior axis of the developing limb bud (By similarity). Essential for axon guidance (By similarity). Binds to the patched (PTCH1) receptor, which functions in association with smoothened (SMO), to activate the transcription of target genes (PubMed:10753901). In the absence of SHH, PTCH1 represses the constitutive signaling activity of SMO (PubMed:10753901)","subcellular_location":"Cell membrane","url":"https://www.uniprot.org/uniprotkb/Q15465/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SHH","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SHH","total_profiled":1310},"omim":[{"mim_id":"621386","title":"VALENCE-FARAZI CEREBELLAR ATAXIA SYNDROME; VAFCAS","url":"https://www.omim.org/entry/621386"},{"mim_id":"621301","title":"PROLINE-RICH COILED-COIL PROTEIN 1; PRRC1","url":"https://www.omim.org/entry/621301"},{"mim_id":"621178","title":"TRANSMEMBRANE PROTEIN 161B; TMEM161B","url":"https://www.omim.org/entry/621178"},{"mim_id":"621143","title":"HOLOPROSENCEPHALY 10; HPE10","url":"https://www.omim.org/entry/621143"},{"mim_id":"621003","title":"TRANSCRIPTION FACTOR Sp9; SP9","url":"https://www.omim.org/entry/621003"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"adrenal gland","ntpm":8.2},{"tissue":"liver","ntpm":12.5},{"tissue":"stomach 1","ntpm":9.9},{"tissue":"urinary bladder","ntpm":15.1}],"url":"https://www.proteinatlas.org/search/SHH"},"hgnc":{"alias_symbol":["HHG1","SMMCI","TPT","TPTPS","MCOPCB5"],"prev_symbol":["HPE3","HLP3"]},"alphafold":{"accession":"Q15465","domains":[{"cath_id":"3.30.1380.10","chopping":"47-190","consensus_level":"high","plddt":92.7593,"start":47,"end":190},{"cath_id":"2.170.16.10","chopping":"193-278_301-380","consensus_level":"high","plddt":89.1162,"start":193,"end":380}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15465","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q15465-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q15465-F1-predicted_aligned_error_v6.png","plddt_mean":78.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SHH","jax_strain_url":"https://www.jax.org/strain/search?query=SHH"},"sequence":{"accession":"Q15465","fasta_url":"https://rest.uniprot.org/uniprotkb/Q15465.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q15465/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q15465"}},"corpus_meta":[{"pmid":"24651015","id":"PMC_24651015","title":"Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition.","date":"2014","source":"Cancer cell","url":"https://pubmed.ncbi.nlm.nih.gov/24651015","citation_count":609,"is_preprint":false},{"pmid":"12198547","id":"PMC_12198547","title":"Shh and Gli3 are dispensable for limb skeleton formation but regulate digit number and identity.","date":"2002","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12198547","citation_count":471,"is_preprint":false},{"pmid":"21267586","id":"PMC_21267586","title":"Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroups.","date":"2011","source":"Acta neuropathologica","url":"https://pubmed.ncbi.nlm.nih.gov/21267586","citation_count":407,"is_preprint":false},{"pmid":"9655803","id":"PMC_9655803","title":"The Shh signalling pathway in tooth development: defects in Gli2 and Gli3 mutants.","date":"1998","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/9655803","citation_count":299,"is_preprint":false},{"pmid":"16540513","id":"PMC_16540513","title":"FGF9 and SHH signaling coordinate lung growth and development through regulation of distinct mesenchymal domains.","date":"2006","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/16540513","citation_count":178,"is_preprint":false},{"pmid":"10564585","id":"PMC_10564585","title":"Analysis of PTCH/SMO/SHH pathway genes in medulloblastoma.","date":"2000","source":"Genes, chromosomes & cancer","url":"https://pubmed.ncbi.nlm.nih.gov/10564585","citation_count":154,"is_preprint":false},{"pmid":"31664194","id":"PMC_31664194","title":"Recurrent noncoding U1 snRNA mutations drive cryptic splicing in SHH medulloblastoma.","date":"2019","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/31664194","citation_count":152,"is_preprint":false},{"pmid":"26771489","id":"PMC_26771489","title":"WNT-SHH Antagonism Specifies and Expands Stem Cells prior to Niche Formation.","date":"2016","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26771489","citation_count":137,"is_preprint":false},{"pmid":"21658586","id":"PMC_21658586","title":"Lhx6 and Lhx8 coordinately induce neuronal expression of Shh that controls the generation of interneuron progenitors.","date":"2011","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/21658586","citation_count":127,"is_preprint":false},{"pmid":"31147463","id":"PMC_31147463","title":"Preformed chromatin topology assists transcriptional robustness of Shh during limb development.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31147463","citation_count":126,"is_preprint":false},{"pmid":"14602680","id":"PMC_14602680","title":"Interplays of Gli2 and Gli3 and their requirement in mediating Shh-dependent sclerotome induction.","date":"2003","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/14602680","citation_count":123,"is_preprint":false},{"pmid":"25833741","id":"PMC_25833741","title":"Ptch1 and Gli regulate Shh signalling dynamics via multiple mechanisms.","date":"2015","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25833741","citation_count":120,"is_preprint":false},{"pmid":"17881491","id":"PMC_17881491","title":"FGF9 and SHH regulate mesenchymal Vegfa expression and development of the pulmonary capillary network.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17881491","citation_count":120,"is_preprint":false},{"pmid":"12210117","id":"PMC_12210117","title":"Shh-Bmp2 signaling module and the evolutionary origin and diversification of feathers.","date":"2002","source":"The Journal of experimental zoology","url":"https://pubmed.ncbi.nlm.nih.gov/12210117","citation_count":119,"is_preprint":false},{"pmid":"31511252","id":"PMC_31511252","title":"Developmentally regulated Shh expression is robust to TAD perturbations.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31511252","citation_count":118,"is_preprint":false},{"pmid":"14550418","id":"PMC_14550418","title":"The emergent design of the neural tube: prepattern, SHH morphogen and GLI code.","date":"2003","source":"Current opinion in genetics & development","url":"https://pubmed.ncbi.nlm.nih.gov/14550418","citation_count":100,"is_preprint":false},{"pmid":"25344580","id":"PMC_25344580","title":"Tumor-associated macrophages in SHH subgroup of medulloblastomas.","date":"2014","source":"Clinical cancer research : an official journal of the American Association for Cancer Research","url":"https://pubmed.ncbi.nlm.nih.gov/25344580","citation_count":97,"is_preprint":false},{"pmid":"19224309","id":"PMC_19224309","title":"SHH pathway and cerebellar development.","date":"2009","source":"Cerebellum (London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19224309","citation_count":94,"is_preprint":false},{"pmid":"9186057","id":"PMC_9186057","title":"Shh expression in developing and regenerating limb buds of Xenopus laevis.","date":"1997","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/9186057","citation_count":86,"is_preprint":false},{"pmid":"26745863","id":"PMC_26745863","title":"A Shh-Foxf-Fgf18-Shh Molecular Circuit Regulating Palate Development.","date":"2016","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26745863","citation_count":78,"is_preprint":false},{"pmid":"33741928","id":"PMC_33741928","title":"The transcriptional landscape of Shh medulloblastoma.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/33741928","citation_count":77,"is_preprint":false},{"pmid":"10225999","id":"PMC_10225999","title":"Expression of ptc and gli genes in talpid3 suggests bifurcation in Shh pathway.","date":"1999","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/10225999","citation_count":76,"is_preprint":false},{"pmid":"19855020","id":"PMC_19855020","title":"A BMP-Shh negative-feedback loop restricts Shh expression during limb development.","date":"2009","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/19855020","citation_count":71,"is_preprint":false},{"pmid":"25252942","id":"PMC_25252942","title":"Mapping the Shh long-range regulatory domain.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25252942","citation_count":70,"is_preprint":false},{"pmid":"15322912","id":"PMC_15322912","title":"Induction and specification of midbrain dopaminergic cells: focus on SHH, FGF8, and TGF-beta.","date":"2004","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/15322912","citation_count":64,"is_preprint":false},{"pmid":"16722608","id":"PMC_16722608","title":"Solitary median maxillary central incisor (SMMCI) syndrome.","date":"2006","source":"Orphanet journal of rare diseases","url":"https://pubmed.ncbi.nlm.nih.gov/16722608","citation_count":62,"is_preprint":false},{"pmid":"9858693","id":"PMC_9858693","title":"Overlapping and non-overlapping Ptch2 expression with Shh during mouse embryogenesis.","date":"1998","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/9858693","citation_count":61,"is_preprint":false},{"pmid":"11130177","id":"PMC_11130177","title":"The role of cholesterol in Shh signaling and teratogen-induced holoprosencephaly.","date":"2000","source":"Cellular and molecular life sciences : CMLS","url":"https://pubmed.ncbi.nlm.nih.gov/11130177","citation_count":60,"is_preprint":false},{"pmid":"15308259","id":"PMC_15308259","title":"PTC gene mutations and expression of SHH, PTC, SMO, and GLI-1 in odontogenic keratocysts.","date":"2004","source":"International journal of oral and maxillofacial surgery","url":"https://pubmed.ncbi.nlm.nih.gov/15308259","citation_count":60,"is_preprint":false},{"pmid":"15128061","id":"PMC_15128061","title":"Expression of Sonic hedgehog (SHH) signaling molecules in ameloblastomas.","date":"2004","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/15128061","citation_count":53,"is_preprint":false},{"pmid":"21093585","id":"PMC_21093585","title":"Foxa1 and Foxa2 positively and negatively regulate Shh signalling to specify ventral midbrain progenitor identity.","date":"2010","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/21093585","citation_count":52,"is_preprint":false},{"pmid":"32990091","id":"PMC_32990091","title":"The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma.","date":"2020","source":"Expert opinion on therapeutic targets","url":"https://pubmed.ncbi.nlm.nih.gov/32990091","citation_count":51,"is_preprint":false},{"pmid":"11002335","id":"PMC_11002335","title":"Control of Shh activity and signaling in the neural tube.","date":"2000","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/11002335","citation_count":51,"is_preprint":false},{"pmid":"26762695","id":"PMC_26762695","title":"The many lives of SHH in limb development and evolution.","date":"2016","source":"Seminars in cell & developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/26762695","citation_count":49,"is_preprint":false},{"pmid":"25263791","id":"PMC_25263791","title":"The Shh receptor Boc promotes progression of early medulloblastoma to advanced tumors.","date":"2014","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25263791","citation_count":48,"is_preprint":false},{"pmid":"34162750","id":"PMC_34162750","title":"A self-amplifying loop of YAP and SHH drives formation and expansion of heterotopic ossification.","date":"2021","source":"Science translational medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34162750","citation_count":43,"is_preprint":false},{"pmid":"15592520","id":"PMC_15592520","title":"Constitutive activation of the shh-ptc1 pathway by a patched1 mutation identified in BCC.","date":"2005","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/15592520","citation_count":43,"is_preprint":false},{"pmid":"35132078","id":"PMC_35132078","title":"Mesenchymal-epithelial crosstalk shapes intestinal regionalisation via Wnt and Shh signalling.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35132078","citation_count":41,"is_preprint":false},{"pmid":"17611415","id":"PMC_17611415","title":"Shh signaling and pancreatic cancer: implications for therapy?","date":"2007","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/17611415","citation_count":41,"is_preprint":false},{"pmid":"25085974","id":"PMC_25085974","title":"Ptch2 mediates the Shh response in Ptch1-/- cells.","date":"2014","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25085974","citation_count":40,"is_preprint":false},{"pmid":"25816987","id":"PMC_25816987","title":"The Eya1 phosphatase promotes Shh signaling during hindbrain development and oncogenesis.","date":"2015","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/25816987","citation_count":38,"is_preprint":false},{"pmid":"12587914","id":"PMC_12587914","title":"Patterning the limb before and after SHH signalling.","date":"2003","source":"Journal of anatomy","url":"https://pubmed.ncbi.nlm.nih.gov/12587914","citation_count":37,"is_preprint":false},{"pmid":"16376138","id":"PMC_16376138","title":"Epithelial expression of SHH signaling pathway in odontogenic tumors.","date":"2005","source":"Oral oncology","url":"https://pubmed.ncbi.nlm.nih.gov/16376138","citation_count":36,"is_preprint":false},{"pmid":"25215859","id":"PMC_25215859","title":"Shh-mediated degradation of Hhip allows cell autonomous and non-cell autonomous Shh signalling.","date":"2014","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/25215859","citation_count":36,"is_preprint":false},{"pmid":"23284750","id":"PMC_23284750","title":"Epigenetic changes in Basal Cell Carcinoma affect SHH and WNT signaling components.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23284750","citation_count":36,"is_preprint":false},{"pmid":"19014928","id":"PMC_19014928","title":"Shh and ROCK1 modulate the dynamic epithelial morphogenesis in circumvallate papilla development.","date":"2008","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/19014928","citation_count":36,"is_preprint":false},{"pmid":"26027634","id":"PMC_26027634","title":"SHH inhibitors for the treatment of medulloblastoma.","date":"2015","source":"Expert review of neurotherapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/26027634","citation_count":35,"is_preprint":false},{"pmid":"20821230","id":"PMC_20821230","title":"Expression of SHH signaling pathway components in the developing human lung.","date":"2010","source":"Histochemistry and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20821230","citation_count":35,"is_preprint":false},{"pmid":"35969743","id":"PMC_35969743","title":"O-GlcNAcylation promotes cerebellum development and medulloblastoma oncogenesis via SHH signaling.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35969743","citation_count":35,"is_preprint":false},{"pmid":"26825960","id":"PMC_26825960","title":"MAPK and SHH pathways modulate type 3 deiodinase expression in papillary thyroid carcinoma.","date":"2016","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/26825960","citation_count":35,"is_preprint":false},{"pmid":"16448649","id":"PMC_16448649","title":"Differential epithelial expression of SHH and FOXF1 in usual and nonspecific interstitial pneumonia.","date":"2006","source":"Experimental and molecular pathology","url":"https://pubmed.ncbi.nlm.nih.gov/16448649","citation_count":35,"is_preprint":false},{"pmid":"33060130","id":"PMC_33060130","title":"The hedgehog co-receptor BOC differentially regulates SHH signaling during craniofacial development.","date":"2020","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/33060130","citation_count":35,"is_preprint":false},{"pmid":"18177854","id":"PMC_18177854","title":"Sequential and cooperative action of Fgfs and Shh in the zebrafish retina.","date":"2007","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/18177854","citation_count":34,"is_preprint":false},{"pmid":"31685615","id":"PMC_31685615","title":"SHH signaling mediated by a prechordal and brain enhancer controls forebrain organization.","date":"2019","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/31685615","citation_count":32,"is_preprint":false},{"pmid":"35547747","id":"PMC_35547747","title":"Shh and Olig2 sequentially regulate oligodendrocyte differentiation from hiPSCs for the treatment of ischemic stroke.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35547747","citation_count":32,"is_preprint":false},{"pmid":"26757905","id":"PMC_26757905","title":"Role of Sonic Hedgehog (Shh) Signaling in Bladder Cancer Stemness and Tumorigenesis.","date":"2016","source":"Current urology reports","url":"https://pubmed.ncbi.nlm.nih.gov/26757905","citation_count":32,"is_preprint":false},{"pmid":"30078728","id":"PMC_30078728","title":"Polarized Dock Activity Drives Shh-Mediated Axon Guidance.","date":"2018","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/30078728","citation_count":31,"is_preprint":false},{"pmid":"30645190","id":"PMC_30645190","title":"SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma.","date":"2019","source":"Endocrine-related cancer","url":"https://pubmed.ncbi.nlm.nih.gov/30645190","citation_count":31,"is_preprint":false},{"pmid":"25799573","id":"PMC_25799573","title":"Cranial nerve development requires co-ordinated Shh and canonical Wnt signaling.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25799573","citation_count":31,"is_preprint":false},{"pmid":"25636508","id":"PMC_25636508","title":"Interaction of sonic hedgehog (SHH) pathway with cancer stem cell genes in gastric cancer.","date":"2015","source":"Medical oncology (Northwood, London, England)","url":"https://pubmed.ncbi.nlm.nih.gov/25636508","citation_count":30,"is_preprint":false},{"pmid":"32682910","id":"PMC_32682910","title":"Inhibition of Shh Signaling through MAPK Activation Controls Chemotherapy-Induced Alopecia.","date":"2020","source":"The Journal of investigative dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/32682910","citation_count":30,"is_preprint":false},{"pmid":"23566240","id":"PMC_23566240","title":"Expression of SHH signaling molecules in the developing human primary dentition.","date":"2013","source":"BMC developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/23566240","citation_count":30,"is_preprint":false},{"pmid":"30214623","id":"PMC_30214623","title":"Intragland Shh gene delivery mitigated irradiation-induced hyposalivation in a miniature pig model.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/30214623","citation_count":30,"is_preprint":false},{"pmid":"30610878","id":"PMC_30610878","title":"Triptonide inhibits lung cancer cell tumorigenicity by selectively attenuating the Shh-Gli1 signaling pathway.","date":"2019","source":"Toxicology and applied pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/30610878","citation_count":29,"is_preprint":false},{"pmid":"32929330","id":"PMC_32929330","title":"Dysregulated Kras/YY1/ZNF322A/Shh transcriptional axis enhances neo-angiogenesis to promote lung cancer progression.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32929330","citation_count":29,"is_preprint":false},{"pmid":"18271755","id":"PMC_18271755","title":"Shh and forebrain evolution in the blind cavefish Astyanax mexicanus.","date":"2008","source":"Biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/18271755","citation_count":28,"is_preprint":false},{"pmid":"17409116","id":"PMC_17409116","title":"Protease nexin 1 and its receptor LRP modulate SHH signalling during cerebellar development.","date":"2007","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/17409116","citation_count":28,"is_preprint":false},{"pmid":"28137592","id":"PMC_28137592","title":"Usp7 promotes medulloblastoma cell survival and metastasis by activating Shh pathway.","date":"2017","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/28137592","citation_count":27,"is_preprint":false},{"pmid":"27317806","id":"PMC_27317806","title":"Rx3 and Shh direct anisotropic growth and specification in the zebrafish tuberal/anterior hypothalamus.","date":"2016","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/27317806","citation_count":27,"is_preprint":false},{"pmid":"19683074","id":"PMC_19683074","title":"Shh and Pax6 have unconventional expression patterns in embryonic morphogenesis in Sepia officinalis (Cephalopoda).","date":"2009","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/19683074","citation_count":27,"is_preprint":false},{"pmid":"24930892","id":"PMC_24930892","title":"Transcriptional profiles of SHH pathway genes in keratocystic odontogenic tumor and ameloblastoma.","date":"2014","source":"Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology","url":"https://pubmed.ncbi.nlm.nih.gov/24930892","citation_count":27,"is_preprint":false},{"pmid":"35403480","id":"PMC_35403480","title":"CGRP and Shh Mediate the Dental Pulp Cell Response to Neuron Stimulation.","date":"2022","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/35403480","citation_count":25,"is_preprint":false},{"pmid":"31488567","id":"PMC_31488567","title":"Genomic architecture of Shh-dependent cochlear morphogenesis.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31488567","citation_count":25,"is_preprint":false},{"pmid":"31139698","id":"PMC_31139698","title":"Principles of tumorigenesis and emerging molecular drivers of SHH-activated medulloblastomas.","date":"2019","source":"Annals of clinical and translational neurology","url":"https://pubmed.ncbi.nlm.nih.gov/31139698","citation_count":25,"is_preprint":false},{"pmid":"27662839","id":"PMC_27662839","title":"Potential role of Shh-Gli1-BMI1 signaling pathway nexus in glioma chemoresistance.","date":"2016","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27662839","citation_count":24,"is_preprint":false},{"pmid":"26413810","id":"PMC_26413810","title":"Shh and p50/Bcl3 signaling crosstalk drives pathogenesis of BCCs in Gorlin syndrome.","date":"2015","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/26413810","citation_count":24,"is_preprint":false},{"pmid":"32958873","id":"PMC_32958873","title":"Berberine inhibits colorectal tumor growth by suppressing SHH secretion.","date":"2020","source":"Acta pharmacologica Sinica","url":"https://pubmed.ncbi.nlm.nih.gov/32958873","citation_count":24,"is_preprint":false},{"pmid":"37315133","id":"PMC_37315133","title":"Yap controls notochord formation and neural tube patterning by integrating mechanotransduction with FoxA2 and Shh expression.","date":"2023","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/37315133","citation_count":22,"is_preprint":false},{"pmid":"33390589","id":"PMC_33390589","title":"Dysfunction of Shh signaling activates autophagy to inhibit trophoblast motility in recurrent miscarriage.","date":"2021","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33390589","citation_count":22,"is_preprint":false},{"pmid":"38191555","id":"PMC_38191555","title":"Developmental basis of SHH medulloblastoma heterogeneity.","date":"2024","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/38191555","citation_count":21,"is_preprint":false},{"pmid":"29582169","id":"PMC_29582169","title":"Medulloblastoma, WNT-activated/SHH-activated: clinical impact of molecular analysis and histogenetic evaluation.","date":"2018","source":"Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery","url":"https://pubmed.ncbi.nlm.nih.gov/29582169","citation_count":21,"is_preprint":false},{"pmid":"27021743","id":"PMC_27021743","title":"Rescue Effects and Underlying Mechanisms of Intragland Shh Gene Delivery on Irradiation-Induced Hyposalivation.","date":"2016","source":"Human gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/27021743","citation_count":21,"is_preprint":false},{"pmid":"23555697","id":"PMC_23555697","title":"Bmp and Shh signaling mediate the expression of satb2 in the pharyngeal arches.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23555697","citation_count":20,"is_preprint":false},{"pmid":"24370450","id":"PMC_24370450","title":"Midline-derived Shh regulates mesonephric tubule formation through the paraxial mesoderm.","date":"2013","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/24370450","citation_count":20,"is_preprint":false},{"pmid":"21046643","id":"PMC_21046643","title":"A cascade of irx1a and irx2a controls shh expression during retinogenesis.","date":"2010","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/21046643","citation_count":20,"is_preprint":false},{"pmid":"30761741","id":"PMC_30761741","title":"EIF5A regulates proliferation and chemoresistance in pancreatic cancer through the sHH signalling pathway.","date":"2019","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/30761741","citation_count":19,"is_preprint":false},{"pmid":"32110934","id":"PMC_32110934","title":"SHH Signaling Pathway Drives Pediatric Bone Sarcoma Progression.","date":"2020","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/32110934","citation_count":18,"is_preprint":false},{"pmid":"31048318","id":"PMC_31048318","title":"The Shh receptor Boc is important for myelin formation and repair.","date":"2019","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/31048318","citation_count":18,"is_preprint":false},{"pmid":"32060146","id":"PMC_32060146","title":"Blocking SHH/Patched Interaction Triggers Tumor Growth Inhibition through Patched-Induced Apoptosis.","date":"2020","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/32060146","citation_count":18,"is_preprint":false},{"pmid":"34463328","id":"PMC_34463328","title":"Identification of disease-relevant modulators of the SHH pathway in the developing brain.","date":"2021","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/34463328","citation_count":18,"is_preprint":false},{"pmid":"29481312","id":"PMC_29481312","title":"Upstream Enhancer Elements of Shh Regulate Oral and Dental Patterning.","date":"2018","source":"Journal of dental research","url":"https://pubmed.ncbi.nlm.nih.gov/29481312","citation_count":17,"is_preprint":false},{"pmid":"38898530","id":"PMC_38898530","title":"SHH induces macrophage oxidative phosphorylation and efferocytosis to promote scar formation.","date":"2024","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/38898530","citation_count":16,"is_preprint":false},{"pmid":"10869115","id":"PMC_10869115","title":"Are triphalangeal thumb-polysyndactyly syndrome (TPTPS) and tibial hemimelia-polysyndactyly-triphalangeal thumb syndrome (THPTTS) identical? A father with TPTPS and his daughter with THPTTS in a Thai family.","date":"2000","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10869115","citation_count":16,"is_preprint":false},{"pmid":"31058710","id":"PMC_31058710","title":"Sonic hedgehog (Shh) and CC chemokine ligand 2 signaling pathways in asthma.","date":"2019","source":"Journal of the Chinese Medical Association : JCMA","url":"https://pubmed.ncbi.nlm.nih.gov/31058710","citation_count":16,"is_preprint":false},{"pmid":"35656621","id":"PMC_35656621","title":"Toosendanin inhibits colorectal cancer cell growth through the Hedgehog pathway by targeting Shh.","date":"2022","source":"Drug development research","url":"https://pubmed.ncbi.nlm.nih.gov/35656621","citation_count":16,"is_preprint":false},{"pmid":"20619754","id":"PMC_20619754","title":"Expression of Sonic hedgehog (SHH) and CDX2 in the columnar epithelium of the lower oesophagus.","date":"2010","source":"Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver","url":"https://pubmed.ncbi.nlm.nih.gov/20619754","citation_count":16,"is_preprint":false},{"pmid":"31292920","id":"PMC_31292920","title":"QKI deficiency maintains glioma stem cell stemness by activating the SHH/GLI1 signaling pathway.","date":"2019","source":"Cellular oncology (Dordrecht, Netherlands)","url":"https://pubmed.ncbi.nlm.nih.gov/31292920","citation_count":16,"is_preprint":false},{"pmid":"35864091","id":"PMC_35864091","title":"Etv2 regulates enhancer chromatin status to initiate Shh expression in the limb bud.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35864091","citation_count":15,"is_preprint":false},{"pmid":"24480851","id":"PMC_24480851","title":"A dual role for SHH during phallus development in a marsupial.","date":"2014","source":"Sexual development : genetics, molecular biology, evolution, endocrinology, embryology, and pathology of sex determination and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/24480851","citation_count":15,"is_preprint":false},{"pmid":"25060182","id":"PMC_25060182","title":"Expression and clinical significance of Shh/Gli-1 in papillary thyroid carcinoma.","date":"2014","source":"Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine","url":"https://pubmed.ncbi.nlm.nih.gov/25060182","citation_count":14,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45627,"output_tokens":8285,"usd":0.130578,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":18117,"output_tokens":7608,"usd":0.140393,"stage2_stop_reason":"end_turn"},"total_usd":0.270971,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Genetic epistasis in mice showed that Shh and Gli3 are dispensable for limb skeletal element formation; Shh(-/-) Gli3(-/-) double mutants have distally complete but polydactylous limbs lacking normal digit identities. The effects of Shh signaling on skeletal patterning are necessarily mediated through Gli3, by regulating the balance of Gli3 transcriptional activator and repressor activities.\",\n      \"method\": \"Genetic double-mutant analysis (Shh-/- Gli3-/- mice), skeletal preparation and phenotypic analysis\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic epistasis with rigorous double-mutant analysis, replicated in multiple contexts, foundational mechanistic result\",\n      \"pmids\": [\"12198547\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Shh protein applied ectopically to mandibular mesenchyme induced expression of Ptc and Gli1, demonstrating that SHH can act as a direct inducer of these pathway targets. Ectopic Shh within tooth germs caused abnormal epithelial invagination, indicating a role for Shh in epithelial cell proliferation during tooth development.\",\n      \"method\": \"Ectopic protein application to explants; in vivo organ culture; mutant analysis (Gli2/Gli3 double mutants)\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — direct protein application assay with target gene readout, replicated in multiple tissue contexts with genetic confirmation\",\n      \"pmids\": [\"9655803\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Using mutant analysis and in vitro explant assays, Gli2 and Gli3 were shown to be required for Shh-dependent sclerotome induction; somitic mesoderm from Gli2(-/-)Gli3(-/-) embryos cannot activate sclerotomal genes in response to exogenous Shh. Additionally, Gli2 was shown to have a repressor function and Gli3 an activator function in the somite, and each Gli preferentially activates a distinct subset of Shh target genes.\",\n      \"method\": \"Genetic mutant analysis, in vitro explant assays, adenoviral Gli overexpression in presomitic mesoderm explants\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods (genetics, explant culture, gain-of-function), clear mechanistic placement of Gli2 and Gli3 as mediators of Shh sclerotome induction\",\n      \"pmids\": [\"14602680\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Cholesterol is important for SHH biogenesis, and teratogens that induce holoprosencephaly (cyclopamine, cholesterol synthesis inhibitors) affect Shh signal transduction in responding cells rather than Shh biogenesis itself. The structural similarity of the Shh receptor Patched (Ptc) to the Niemann-Pick C1 protein (involved in vesicular cholesterol trafficking) implicates cholesterol in Shh signal transduction.\",\n      \"method\": \"Pharmacological inhibitor studies (cyclopamine, cholesterol synthesis inhibitors); review of mechanistic data on Shh processing and pathway activation\",\n      \"journal\": \"Cellular and molecular life sciences : CMLS\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 / Moderate — mechanistic inference from pharmacological studies and structural homology; single review synthesizing multiple experimental datasets; no direct reconstitution\",\n      \"pmids\": [\"11130177\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"FGF9 and SHH signaling coordinate lung mesenchymal development through distinct sub-mesothelial and sub-epithelial compartments. FGF9 signals from the epithelium to sub-epithelial mesenchyme to maintain SHH signaling, which regulates cell proliferation, survival and mesenchymal-to-epithelial signaling. FGF9 alone can only partially rescue vascular defects caused by SHH loss, and SHH cannot rescue FGF9-null vascular phenotypes, indicating they regulate distinct aspects of development.\",\n      \"method\": \"Loss-of-function and inducible gain-of-function mouse models (Fgf9 KO, Shh signaling loss), phenotypic and gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — reciprocal gain/loss of function genetics, two independent mouse models, clear pathway epistasis with defined cellular phenotypes\",\n      \"pmids\": [\"16540513\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"FGF9 and SHH signaling to lung mesenchyme (but not to endothelial cells) are each necessary and together sufficient for distal pulmonary capillary development, acting by regulating Vegfa expression in lung mesenchyme. VEGF signaling is required downstream of FGF9-mediated blood vessel formation.\",\n      \"method\": \"Gain- and loss-of-function genetics in mice, conditional deletion, Vegfa expression analysis, vascular morphometry\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — dual gain/loss of function mouse models with clear cellular phenotype readout, pathway epistasis established\",\n      \"pmids\": [\"17881491\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"BMP activity negatively regulates Shh transcription in the limb bud, forming a BMP-Shh negative-feedback loop that confines Shh expression to the ZPA. BMP-dependent downregulation of Shh is achieved by interfering with FGF and Wnt signaling activities that maintain Shh expression. FGF induction of Shh requires protein synthesis and is mediated by the ERK1/2 MAPK pathway.\",\n      \"method\": \"In vivo limb bud manipulation, pharmacological inhibitors (ERK1/2 MAPK), gene expression analysis, gain- and loss-of-function experiments\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal approaches (genetics, pharmacology, expression), single lab, mechanistic dissection of feedback loop\",\n      \"pmids\": [\"19855020\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Lhx6 and Lhx8 transcription factors coexpressed in early-born MGE neurons are required to induce neuronal Shh expression. Shh function in early-born MGE neurons feeds forward to promote SHH signaling in the overlying progenitor zone, regulating Lhx6, Lhx8, and Nkx2-1 expression and production of late-born somatostatin+ and parvalbumin+ cortical interneurons.\",\n      \"method\": \"Genetic conditional deletion of Shh in MGE mantle zone, gene expression analysis, interneuron counting\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic conditional KO with defined cellular phenotype and molecular pathway placement, single lab with multiple readouts\",\n      \"pmids\": [\"21658586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Foxa2 positively regulates Shh expression in multiple tissues, but in the midbrain Foxa1 and Foxa2 attenuate Shh signaling by directly inhibiting expression of its intracellular transducer Gli2 at the transcriptional level. ChIP experiments showed that Foxa2 binds to genomic regions of Gli2.\",\n      \"method\": \"Conditional KO of Foxa2 in midbrain (Wnt1cre;Foxa2flox/flox), gain-of-function studies in mice, chromatin immunoprecipitation (ChIP)\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss/gain of function plus direct ChIP binding evidence, single lab, two orthogonal methods\",\n      \"pmids\": [\"21093585\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The Shh gradient amplitude in the mouse neural tube increases over time, but Gli transcriptional effector activity initially increases then decreases (adaptation). Computational and experimental analysis identified three contributing mechanisms: transcriptional upregulation of inhibitory receptor Ptch1, transcriptional downregulation of Gli, and differential stability of active vs. inactive Gli isoforms. Gli2 protein expression is downregulated during neural tube patterning, and adaptation continues when the pathway is stimulated downstream of Ptch1.\",\n      \"method\": \"Quantitative imaging of Shh gradient in developing mouse neural tube, computational modeling, Gli2 protein expression analysis, NIH3T3 cell culture experiments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — quantitative in vivo gradient measurements combined with computational modeling and cell culture validation, multiple orthogonal approaches, single lab\",\n      \"pmids\": [\"25833741\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Ptch2 mediates the Shh response in Ptch1-/- cells. The Shh response in Ptch1(-/-) cells is ligand-dependent and can be inhibited by Shh-blocking antibody 5E1. Ptch1(-/-);Ptch2(-/-) double KO cells cannot further activate the Shh response, demonstrating that Ptch2 mediates Shh signaling in the absence of Ptch1. Expression of dominant-negative Ptch2 in developing chick neural tube caused activation of the Shh response, indicating Ptch2 suppresses Shh signaling at early developmental stages.\",\n      \"method\": \"Ptch1/Ptch2 double KO cells, Shh-blocking antibody (5E1), dominant-negative Ptch constructs in chick neural tube electroporation, cell migration assays\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic double KO combined with antibody blocking and dominant-negative approaches, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"25085974\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Shh-induced activation of Smoothened (Smo) drastically increases Hhip (Hedgehog-interacting protein) internalization and degradation cell-autonomously. While Hhip can leave its site of synthesis to inhibit Shh non-cell-autonomously, it cannot cell-autonomously inhibit the consequences of Smo activation. This provides a mechanism by which Shh activates pathway response while negating cell-autonomous effects of Hhip, yet Hhip retains non-cell-autonomous inhibitory capacity.\",\n      \"method\": \"Hhip overexpression and localization assays, Smo activation studies, internalization and degradation assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — direct cell biological assays of Hhip internalization upon Smo activation, single lab, multiple orthogonal readouts\",\n      \"pmids\": [\"25215859\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Boc (a Shh-binding protein) associates with the Shh receptor Ptch1 to mediate Shh signaling. Boc, through elevated Shh signaling, promotes high levels of DNA damage mediated by CyclinD1. High DNA damage in the presence of Boc increases the incidence of Ptch1 loss of heterozygosity, driving progression from early to advanced medulloblastoma.\",\n      \"method\": \"Boc genetic inactivation in mice, medulloblastoma progression analysis, CyclinD1 mechanistic studies, DNA damage assays\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO in mouse tumor model with defined molecular mechanism (CyclinD1-mediated DNA damage), single lab\",\n      \"pmids\": [\"25263791\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Eya1 phosphatase, acting together with the DNA-binding protein Six1, promotes gene induction in response to Shh by regulating Gli transcriptional activators. Eya1 was identified via shRNA screen of the phosphatome and is required for Shh-dependent hindbrain growth; catalytically active Eya1 (its phosphatase activity) is necessary for this function.\",\n      \"method\": \"shRNA screen of phosphatome, loss-of-function and gain-of-function assays, catalytic mutant analysis, in vivo genetic analysis of hindbrain development\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — unbiased screen plus mechanistic follow-up with catalytic mutagenesis and in vivo validation, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"25816987\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Shh-mediated axon guidance of commissural neurons requires Dock3/4 GEFs and their binding partners ELMO1/2. Mechanistically, Dock and ELMO interact with Boc (the Shh receptor), and this interaction is reduced upon Shh stimulation. Shh stimulation translocates ELMO to the growth cone periphery and activates Rac1, identifying Dock/ELMO as an effector complex of non-canonical Shh signaling for growth cone turning.\",\n      \"method\": \"shRNA knockdown in vitro axon turning assays, in vivo commissural axon guidance analysis, co-immunoprecipitation of Dock/ELMO with Boc, Rac1 activation assays, subcellular localization imaging\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP binding partner identification, in vitro and in vivo KD with specific axon guidance phenotype, Rac1 activation assay, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"30078728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Protease nexin 1 (PN-1/SERPINE2) interacts with LRP (low-density lipoprotein receptor-related proteins) to antagonize SHH-induced CGNP proliferation and inhibit GLI1 transcriptional activity. PN-1 binding to LRPs interferes with SHH-induced cyclin D1 expression. CGNPs from Pn-1-deficient mice show enhanced basal proliferation due to overactivation of the SHH pathway.\",\n      \"method\": \"PN-1 knockout mouse analysis, proliferation assays, GLI1 activity assays, cyclin D1 expression analysis, binding studies with LRP\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with defined molecular mechanism (LRP interaction, cyclin D1), multiple readouts, single lab\",\n      \"pmids\": [\"17409116\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Highly recurrent U1 snRNA hotspot mutations (r.3A>G) in ~50% of SHH medulloblastomas occur in the 5' splice-site binding region and cause disrupted RNA splicing with excess 5' cryptic splicing events. Mutant U1 snRNA-mediated alternative splicing inactivates tumor-suppressor PTCH1 and activates oncogenes GLI2 and CCND2, identifying a non-canonical mechanism of SHH pathway activation.\",\n      \"method\": \"Whole-genome/transcriptome sequencing of 250 SHH medulloblastomas, splicing analysis, functional characterization of U1 snRNA mutations\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — large cohort sequencing with functional splicing validation, mechanistically links U1 snRNA mutation to SHH pathway activation, independently strong evidence\",\n      \"pmids\": [\"31664194\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"In developing hair buds, SHH signaling is differentially distributed between asymmetric daughter cells: displaced WNT-low suprabasal daughters become stem cells that respond to paracrine SHH and symmetrically expand, while basal daughters express but do not respond to SHH. This WNT-SHH antagonism specifies and expands stem cells prior to niche formation.\",\n      \"method\": \"Live imaging, immunofluorescence, genetics, cell-cycle analyses, in utero lentiviral transduction, lineage tracing\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple orthogonal methods including live imaging, lineage tracing and genetics in single study, clear mechanistic link between SHH/WNT pathway distribution and cell fate\",\n      \"pmids\": [\"26771489\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"YAP transcription activity, activated downstream of GNAS loss, directly drives Shh expression. Secreted SHH in turn induces YAP activation, Shh expression, and osteoblast differentiation in surrounding wild-type cells, forming a self-amplifying YAP-SHH loop that is necessary and sufficient for heterotopic ossification expansion. Genetic or pharmacological inhibition of either YAP or SHH abolished HO.\",\n      \"method\": \"Mouse models of POH (Gnas KO) and FOP, genetic ablation and pharmacological inhibition of YAP and SHH, gain-of-function experiments, gene expression analysis\",\n      \"journal\": \"Science translational medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple disease mouse models, genetic and pharmacological inhibition of both nodes, demonstration of both necessity and sufficiency, single lab with multiple orthogonal approaches\",\n      \"pmids\": [\"34162750\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"O-GlcNAc transferase (OGT) regulates granule neuron precursor neurogenesis by activating the Shh signaling pathway via O-GlcNAcylation at S355 of Gli2. This modification promotes Gli2 deacetylation and transcriptional activity through dissociation from p300 (a histone acetyltransferase). OGT inhibition improves survival in a medulloblastoma mouse model.\",\n      \"method\": \"OGT conditional KO, O-GlcNAcylation site mapping (S355 of Gli2), Gli2-p300 co-immunoprecipitation, acetylation/deacetylation assays, medulloblastoma mouse model\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — PTM site identification (S355), biochemical dissection of Gli2-p300 interaction, genetic KO in vivo, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"35969743\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Wnt signaling directly regulates epithelial expression of Sonic Hedgehog (SHH), which in turn acts on mesenchymal cells to drive villi formation during small intestine morphogenesis. Subepithelial mesenchymal cell gradients supporting Wnt signaling regulate epithelial SHH expression as part of a mesenchymal-epithelial crosstalk.\",\n      \"method\": \"Single-cell analysis, in vitro organoid culture, genetic manipulation, in situ hybridization, gene expression analysis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — mechanistic pathway placement with genetic and functional experiments, single lab, multiple readouts\",\n      \"pmids\": [\"35132078\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"A prechordal enhancer (SBE7) was identified that directs Shh expression in both the prechordal plate and ventral midline of the forebrain. Deletion of SBE7 from the mouse genome markedly downregulated Shh in the rostral axial mesoderm and ventral forebrain/hypothalamus, causing craniofacial abnormality resembling human holoprosencephaly. Prechordal SHH signaling triggers secondary Shh induction in the forebrain, which then directs neuronal differentiation.\",\n      \"method\": \"Enhancer identification, targeted deletion from mouse genome, in vivo reporter assays, gene expression analysis\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — targeted genome deletion with defined in vivo phenotype and two-step signaling cascade, single lab, multiple readouts\",\n      \"pmids\": [\"31685615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Abrogating constitutive transcription over the ZRS enhancer shifts Shh-ZRS contacts and moderately reduces Shh transcription. Deletion of CTCF binding sites around the ZRS results in loss of the preformed Shh-ZRS interaction and 50% decrease in Shh expression but no detectable phenotype, indicating an additional CTCF-independent mechanism. Combining CTCF binding site loss with a hypomorphic ZRS allele causes severe Shh loss of function and digit agenesis.\",\n      \"method\": \"CTCF binding site deletion, hypomorphic ZRS allele, chromosome conformation capture, in vivo mouse genetics\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — multiple independent genetic deletions in mice with 3D chromatin conformation analysis, clear mechanistic dissection of enhancer-promoter communication, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"31147463\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Foxf2 (downstream of Shh signaling) is required in neural crest-derived palatal mesenchyme for palatogenesis; Foxf1 and Foxf2 together repress Fgf18 expression in the mesenchyme, which is necessary to maintain Shh expression in the palatal epithelium. Addition of exogenous Fgf18 protein to cultured palatal explants directly inhibited Shh expression, establishing a Shh-Foxf-Fgf18-Shh molecular circuit.\",\n      \"method\": \"Cre/loxP tissue-specific conditional KO, RNA-seq, whole-mount in situ hybridization, palatal explant culture with exogenous FGF18 protein\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — conditional genetics combined with direct protein treatment of explants, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"26745863\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"YAP, acting as a mechanosensor, is activated by a gradient of mechanical stress and tissue stiffness in the notochord and ventral neural tube. YAP activation induces FoxA2 and Shh expression; Hedgehog signaling activation rescues neural tube patterning defects caused by Yap deficiency (but not notochord formation), establishing that mechanotransduction via Yap acts in a feedforward mechanism to activate Shh expression for floor plate induction.\",\n      \"method\": \"Yap conditional KO mice, gain-of-function experiments, mechanical stress measurement, tissue stiffness analysis, Hedgehog signaling rescue experiments\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with rescue experiments, mechanistic dissection of upstream regulator of Shh expression, single lab, multiple readouts\",\n      \"pmids\": [\"37315133\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"ETV2 acts as a pioneer transcription factor that initiates Shh expression by changing chromatin status at the ZRS limb enhancer. Etv2 expression precedes Shh in limb buds; Etv2 inactivation prevents ZRS chromatin opening and abolishes Shh expression. Etv2 overexpression causes nucleosomal displacement at ZRS, ectopic Shh expression, and polydactyly. ETV2 is also antagonized by ETV4/5 repressors, and known human polydactyl mutations introduce novel ETV2 binding sites in ZRS.\",\n      \"method\": \"Etv2 conditional KO, gain-of-function overexpression, ATAC-seq chromatin accessibility, nucleosome displacement assays, luciferase reporter assays for ETV2 binding sites\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Strong — chromatin accessibility (ATAC-seq) plus genetic gain/loss of function and mechanistic mutagenesis of ETS binding sites, multiple orthogonal methods, single lab\",\n      \"pmids\": [\"35864091\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Notochord/floor plate-derived Shh regulates mesonephric tubule number and position through indirect effects on the paraxial mesoderm (rather than direct regulation). Mesonephros-specific Shh ablation showed that locally-expressed Shh is not required for mesonephric development. Stage-specific ablation and lineage analysis demonstrated that midline-derived Shh regulates nephrogenic gene expression indirectly via the paraxial mesoderm.\",\n      \"method\": \"Shh conditional KO (Hoxb7-Cre, Sall1CreERT2, ShhCreERT2), stage-specific ablation, lineage analysis of Hh-responsive cells, gene expression analysis\",\n      \"journal\": \"Developmental biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple conditional KO models with stage-specific ablation, clear mechanistic dissection of source vs. target tissue, single lab\",\n      \"pmids\": [\"24370450\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"SHH binding to PTCH not only activates the canonical pathway but also blocks PTCH-induced apoptosis (PTCH functions as a dependence receptor that triggers apoptosis in the absence of SHH). Autocrine SHH interference in colon, pancreatic, and lung cancer cell lines triggered cell death through PTCH proapoptotic signaling without changing canonical pathway activity. In vivo, SHH interference decreased primary tumor growth and metastasis.\",\n      \"method\": \"SHH interference (knockdown/blocking) in cancer cell lines, in vivo xenograft models, apoptosis assays, canonical pathway activity measurement\",\n      \"journal\": \"Cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vitro and in vivo loss-of-function with defined apoptotic mechanism, single lab, multiple cancer cell line models\",\n      \"pmids\": [\"32060146\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Downregulation of Shh signaling in the hair matrix is a critical early event in chemotherapy-induced alopecia (CIA). Inhibition of Shh signaling recapitulated key morphological features of CIA, and recombinant Shh protein partially rescued hair loss. Phosphoproteomics identified MAPK pathway activation as a key upstream event that controls Shh downregulation. Shh signaling is an evolutionarily conserved target in CIA pathobiology.\",\n      \"method\": \"Mouse model of CIA, recombinant Shh protein rescue, Shh signaling inhibition, phosphoproteomics, human hair follicle organ culture\",\n      \"journal\": \"The Journal of investigative dermatology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — in vivo mouse model, protein rescue, phosphoproteomics for pathway placement, human follicle validation; single lab\",\n      \"pmids\": [\"32682910\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In developing zebrafish tuberal/anterior hypothalamus, Shh acts as an on-off switch for the homeodomain transcription factor Rx3. Shh coordinates progenitor cell selection and behavior in the tuberal/anterior hypothalamus; in absence of Shh, the shh+ anterior recess does not form and resident differentiated cell types fail to develop.\",\n      \"method\": \"rx3 chk mutant/morphant zebrafish, Shh signaling manipulation, EdU pulse-chase, gene expression analysis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic mutant and morpholino studies with pathway manipulation, defined cellular phenotype, single lab\",\n      \"pmids\": [\"27317806\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Genomic analysis mapped Shh-responsive genes in the otic vesicle using Smo loss-of-function and Shh gain-of-function mouse mutants. Gli2 ChIP-seq combined with ATAC-seq identified inner ear enhancers near Shh-responsive genes, revealing Shh-dependent transcriptional networks controlling cochlear duct morphogenesis.\",\n      \"method\": \"Comparative transcriptomics of Smo KO and Shh gain-of-function mutants, ATAC-seq, Gli2 ChIP-seq\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 / Moderate — ChIP-seq and ATAC-seq plus genetic gain/loss of function, multiple orthogonal genomic methods, single lab\",\n      \"pmids\": [\"31488567\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SHH is a secreted morphogen that signals through binding to its receptor PTCH1 (and co-receptors BOC, GAS1, CDON), relieving PTCH1-mediated inhibition of Smoothened (SMO) to activate GLI transcription factors; its transcription is initiated by pioneer factors such as ETV2 acting on the ZRS enhancer and reinforced by mechanotransduction through YAP/FoxA2, while downstream signaling dynamics are shaped by negative feedback through PTCH1 upregulation and Gli protein stability, and by post-translational modifications including O-GlcNAcylation of GLI2 at S355 that modulates its transcriptional activity; non-canonically, SHH also guides axon growth cones through Boc-Dock/ELMO-Rac1 signaling, blocks PTCH1-induced apoptosis as a survival signal, and forms positive feedback loops (e.g., YAP-SHH in heterotopic ossification) with its effects on target tissues mediated through distinct Gli protein combinations.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SHH is a secreted morphogen that patterns diverse developing tissues by activating the Hedgehog pathway in responding cells, where its effects are transduced through GLI transcription factors that integrate distinct activator and repressor activities [#0, #2]. Applied ectopically, SHH directly induces the pathway targets Ptch and Gli1 and drives epithelial proliferation [#1], and the cellular outcome depends on the GLI repertoire: GLI2 and GLI3 are required to translate the SHH signal into target-gene induction (e.g., sclerotome specification), with each GLI preferentially activating a distinct subset of targets [#0, #2]. SHH signals through the receptor PTCH1, and PTCH2 provides redundant ligand-dependent reception in the absence of PTCH1 [#10]; the co-receptor BOC associates with PTCH1 to potentiate signaling [#12]. Pathway output is shaped by multiple feedback and modulatory inputs—transcriptional upregulation of the inhibitory receptor Ptch1, downregulation of Gli, and differential GLI isoform stability produce signal adaptation over time [#9]; Smo activation drives cell-autonomous internalization and degradation of the antagonist HHIP while preserving HHIP's non-cell-autonomous inhibition [#11]; and GLI activity is tuned by the EYA1/SIX1 phosphatase module [#13] and by O-GlcNAcylation of GLI2 at S355, which promotes GLI2 deacetylation and dissociation from p300 to enhance transcription [#19]. SHH transcription is itself the focus of intricate control: pioneer factor ETV2 opens chromatin at the limb ZRS enhancer to initiate expression [#25], CTCF-dependent enhancer–promoter looping and constitutive transcription sustain ZRS output [#22], a prechordal enhancer (SBE7) directs forebrain/ventral midline expression whose loss models holoprosencephaly [#21], and mechanotransduction through YAP→FoxA2 feeds forward to activate Shh for floor plate induction [#24]. Across tissues SHH operates within reciprocal signaling circuits—with FGF9 in lung mesenchyme and vasculature [#4, #5], BMP/FGF/WNT in the limb and intestine [#6, #20], and FOXF–FGF18 in the palate [#23]. Non-canonically, SHH guides commissural axons by acting through BOC and a DOCK/ELMO–Rac1 effector complex at the growth cone [#14], and acts as a survival signal by blocking PTCH-induced apoptosis when PTCH behaves as a dependence receptor [#27]. Dysregulated SHH signaling drives disease: recurrent U1 snRNA hotspot mutations activate the pathway in SHH medulloblastoma by mis-splicing PTCH1, GLI2, and CCND2 [#16], BOC-dependent DNA damage promotes medulloblastoma progression [#12], and a self-amplifying YAP–SHH loop drives heterotopic ossification [#18].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"Established that SHH protein directly induces canonical pathway targets and drives epithelial proliferation, defining its readouts in responding tissue.\",\n      \"evidence\": \"Ectopic Shh protein application to mandibular/tooth explants with Ptc and Gli1 readout, plus Gli2/Gli3 mutant analysis\",\n      \"pmids\": [\"9655803\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve receptor-level mechanism of induction\", \"Direct vs. relayed induction within the tissue not fully separated\"]\n    },\n    {\n      \"year\": 2000,\n      \"claim\": \"Distinguished SHH biogenesis from signal transduction, placing cholesterol-dependent steps in the receiving cell and linking PTCH function to cholesterol trafficking.\",\n      \"evidence\": \"Pharmacological inhibitor studies (cyclopamine, cholesterol synthesis inhibitors) and structural homology review of Patched to NPC1\",\n      \"pmids\": [\"11130177\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct reconstitution of cholesterol handling by PTCH\", \"Synthesis from heterogeneous datasets, not a single experiment\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Resolved that SHH patterning of the limb skeleton is mediated entirely through GLI3 by setting the activator/repressor balance, rather than by SHH acting independently.\",\n      \"evidence\": \"Shh-/- Gli3-/- double-mutant mouse genetic epistasis with skeletal phenotyping\",\n      \"pmids\": [\"12198547\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not address GLI2 contribution in limb\", \"Molecular control of activator/repressor ratio not defined\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Assigned division of labor among GLI proteins, showing GLI2 and GLI3 are jointly required for SHH-dependent sclerotome induction and each activates distinct target subsets.\",\n      \"evidence\": \"Gli2-/-Gli3-/- mouse genetics, explant assays, adenoviral Gli overexpression in presomitic mesoderm\",\n      \"pmids\": [\"14602680\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target-specificity determinants not identified\", \"Tissue generality of GLI labor division untested\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Defined reciprocal FGF9–SHH crosstalk in lung mesenchyme, showing each pathway controls distinct, non-substitutable aspects of development.\",\n      \"evidence\": \"Reciprocal gain/loss-of-function mouse models with phenotypic and gene-expression analysis\",\n      \"pmids\": [\"16540513\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular intermediaries between FGF9 and SHH not fully mapped\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Showed SHH and FGF9 converge on mesenchymal Vegfa to drive distal pulmonary capillary formation, placing SHH upstream of a defined vascular effector.\",\n      \"evidence\": \"Conditional gain/loss-of-function mouse genetics, Vegfa expression and vascular morphometry\",\n      \"pmids\": [\"17881491\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"GLI-level regulation of Vegfa not directly shown\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified PN-1/SERPINE2–LRP as an extrinsic brake on SHH-induced proliferation, acting via GLI1 and cyclin D1.\",\n      \"evidence\": \"Pn-1 knockout mouse CGNP proliferation assays, GLI1 activity and cyclin D1 readouts, LRP binding studies\",\n      \"pmids\": [\"17409116\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Biochemical mechanism of LRP-mediated GLI1 inhibition incomplete\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Dissected upstream transcriptional control of Shh in the limb, defining a BMP–Shh negative-feedback loop and FGF/ERK-dependent maintenance.\",\n      \"evidence\": \"In vivo limb manipulation, ERK1/2 inhibitors, gain/loss-of-function expression analysis\",\n      \"pmids\": [\"19855020\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct transcription factors mediating BMP repression at Shh not identified\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Revealed FOXA2 as a context-dependent regulator that activates Shh in some tissues but directly represses its transducer Gli2 in midbrain.\",\n      \"evidence\": \"Wnt1cre;Foxa2 conditional KO, gain-of-function, and ChIP of FOXA2 on Gli2 loci\",\n      \"pmids\": [\"21093585\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Determinants of activator vs. repressor context not defined\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placed SHH within a feed-forward neurogenic circuit, showing LHX6/LHX8 induce neuronal Shh that sustains progenitor-zone signaling for interneuron production.\",\n      \"evidence\": \"Conditional Shh deletion in MGE mantle zone, expression analysis, interneuron counting\",\n      \"pmids\": [\"21658586\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct LHX-to-Shh transcriptional link not biochemically resolved\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Distinguished SHH source from target, showing midline-derived SHH patterns mesonephric tubules indirectly via paraxial mesoderm.\",\n      \"evidence\": \"Multiple conditional Shh KO models, stage-specific ablation, lineage analysis\",\n      \"pmids\": [\"24370450\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Intermediate paraxial signal relaying SHH effect not identified\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated receptor redundancy, showing PTCH2 mediates ligand-dependent SHH reception when PTCH1 is absent and normally suppresses signaling.\",\n      \"evidence\": \"Ptch1/Ptch2 double-KO cells, 5E1 blocking antibody, dominant-negative Ptch2 in chick neural tube\",\n      \"pmids\": [\"25085974\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Quantitative contribution of PTCH2 in normal development unclear\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Explained how cells reconcile signaling with the antagonist HHIP, showing Smo activation drives cell-autonomous HHIP degradation while sparing its paracrine inhibition.\",\n      \"evidence\": \"HHIP overexpression/localization, Smo activation, internalization and degradation assays\",\n      \"pmids\": [\"25215859\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Machinery routing HHIP to degradation not identified\", \"Single-lab cell-biological observation\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Linked the co-receptor BOC to oncogenic SHH output, showing BOC potentiates signaling and drives CyclinD1-mediated DNA damage promoting medulloblastoma progression.\",\n      \"evidence\": \"Boc genetic inactivation in mouse medulloblastoma model, CyclinD1 and DNA-damage assays\",\n      \"pmids\": [\"25263791\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism connecting elevated SHH signaling to DNA damage incomplete\", \"Generality beyond this tumor model untested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined the dynamic logic of SHH interpretation, showing GLI activity adapts via Ptch1 upregulation, Gli downregulation, and differential GLI isoform stability.\",\n      \"evidence\": \"Quantitative gradient imaging in mouse neural tube, computational modeling, NIH3T3 validation\",\n      \"pmids\": [\"25833741\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of differential GLI isoform stability not resolved\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identified EYA1/SIX1 phosphatase activity as a positive regulator of GLI activators required for SHH-dependent hindbrain growth.\",\n      \"evidence\": \"Phosphatome shRNA screen, catalytic mutant analysis, in vivo genetics\",\n      \"pmids\": [\"25816987\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GLI dephosphorylation substrate not demonstrated\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Established a Shh-Foxf-Fgf18-Shh circuit in palate, showing FOXF repression of mesenchymal Fgf18 sustains epithelial Shh.\",\n      \"evidence\": \"Tissue-specific conditional KO, RNA-seq, in situ hybridization, FGF18 protein on explants\",\n      \"pmids\": [\"26745863\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct FGF18 repression mechanism on Shh promoter not shown\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Showed WNT-SHH antagonism asymmetrically distributes SHH responsiveness between daughter cells to specify and expand hair follicle stem cells.\",\n      \"evidence\": \"Live imaging, lineage tracing, genetics, cell-cycle analysis in hair buds\",\n      \"pmids\": [\"26771489\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular basis of differential SHH responsiveness between daughters unclear\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Identified SHH as a binary switch controlling Rx3 and progenitor behavior in zebrafish tuberal/anterior hypothalamus.\",\n      \"evidence\": \"rx3 mutant/morphant zebrafish, SHH manipulation, EdU pulse-chase\",\n      \"pmids\": [\"27317806\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism of switch-like Rx3 regulation not defined\", \"Morpholino-based loss of function\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Defined a non-canonical SHH axon-guidance effector pathway operating through BOC and DOCK/ELMO to activate Rac1 at the growth cone.\",\n      \"evidence\": \"shRNA axon-turning assays, in vivo guidance, BOC Co-IP, Rac1 activation, growth-cone imaging\",\n      \"pmids\": [\"30078728\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How SHH binding reduces BOC-DOCK/ELMO association mechanistically unresolved\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified U1 snRNA hotspot mutations as a non-canonical driver of SHH medulloblastoma, mis-splicing PTCH1, GLI2, and CCND2.\",\n      \"evidence\": \"Whole-genome/transcriptome sequencing of 250 tumors with functional splicing characterization\",\n      \"pmids\": [\"31664194\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How a single splicing change coordinately rewires multiple pathway genes not fully mechanized\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Defined enhancer-promoter architecture controlling Shh, showing CTCF-dependent ZRS looping and constitutive transcription jointly sustain expression.\",\n      \"evidence\": \"CTCF site and hypomorphic ZRS deletions, chromosome conformation capture, mouse genetics\",\n      \"pmids\": [\"31147463\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Nature of the CTCF-independent maintenance mechanism unidentified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Identified the prechordal enhancer SBE7 directing forebrain/ventral-midline Shh, whose deletion models holoprosencephaly via a two-step signaling cascade.\",\n      \"evidence\": \"Targeted enhancer deletion, reporter assays, expression analysis in mice\",\n      \"pmids\": [\"31685615\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Trans-acting factors binding SBE7 not identified\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Mapped SHH-responsive transcriptional networks in the otic vesicle, linking GLI2 occupancy to inner-ear enhancers controlling cochlear morphogenesis.\",\n      \"evidence\": \"Smo KO vs. Shh gain-of-function transcriptomics, ATAC-seq, Gli2 ChIP-seq\",\n      \"pmids\": [\"31488567\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional validation of individual identified enhancers limited\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Revealed a survival function of SHH independent of canonical signaling, blocking PTCH dependence-receptor apoptosis in cancer cells.\",\n      \"evidence\": \"SHH interference in colon/pancreatic/lung lines, xenografts, apoptosis and canonical-activity assays\",\n      \"pmids\": [\"32060146\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"PTCH proapoptotic effector machinery not defined\", \"Single-lab cell-line and xenograft scope\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Placed SHH downregulation as an early causal event in chemotherapy-induced alopecia, downstream of MAPK activation.\",\n      \"evidence\": \"Mouse CIA model, recombinant SHH rescue, phosphoproteomics, human follicle organ culture\",\n      \"pmids\": [\"32682910\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct MAPK-to-Shh transcriptional link not established\", \"Single lab\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Defined a self-amplifying YAP–SHH loop downstream of GNAS loss that is necessary and sufficient for heterotopic ossification.\",\n      \"evidence\": \"POH/FOP mouse models, genetic and pharmacological YAP/SHH inhibition, gain-of-function\",\n      \"pmids\": [\"34162750\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct YAP binding at Shh regulatory regions not shown in this context\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identified ETV2 as a pioneer factor that opens ZRS chromatin to initiate Shh expression, with ETV4/5 antagonism and disease-relevant binding-site gains.\",\n      \"evidence\": \"Etv2 conditional KO/overexpression, ATAC-seq, nucleosome displacement, ETS-site reporter assays\",\n      \"pmids\": [\"35864091\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How ETV2 pioneering hands off to sustained ZRS transcription not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Established WNT-to-epithelial-Shh-to-mesenchyme signaling driving intestinal villus formation.\",\n      \"evidence\": \"Single-cell analysis, organoid culture, genetics, in situ hybridization\",\n      \"pmids\": [\"35132078\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct WNT regulation of the Shh promoter not demonstrated\", \"Single lab\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Defined O-GlcNAcylation of GLI2 at S355 as a post-translational switch enhancing GLI2 transcription via deacetylation and p300 dissociation.\",\n      \"evidence\": \"OGT conditional KO, S355 site mapping, Gli2-p300 Co-IP, acetylation assays, medulloblastoma model\",\n      \"pmids\": [\"35969743\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How S355 O-GlcNAcylation mechanistically drives deacetylation not fully resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Identified mechanotransduction as an upstream activator of Shh, showing YAP responds to tissue stiffness to induce FoxA2 and Shh for floor plate induction.\",\n      \"evidence\": \"Yap conditional KO with rescue, mechanical stress/stiffness measurement, Hedgehog rescue\",\n      \"pmids\": [\"37315133\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular link from YAP to Shh transcription in neural tube not shown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the diverse upstream enhancer inputs (ETV2, CTCF looping, YAP/FoxA2, WNT, BMP/FGF) are integrated at the SHH locus to produce tissue-specific expression, and how PTCH dependence-receptor apoptosis is executed at the molecular level, remain open.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No unified model of SHH locus regulation across tissues\", \"PTCH proapoptotic effector pathway undefined\", \"Structural basis of SHH–PTCH1/PTCH2/BOC receptor engagement not addressed in the corpus\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0048018\", \"supporting_discovery_ids\": [1, 10, 12]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [1, 10, 14]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [1, 11, 28]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 10, 9]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [4, 5, 7, 17, 21, 24, 25]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [16, 18, 27, 12]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [22, 24, 25, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PTCH1\", \"PTCH2\", \"BOC\", \"HHIP\", \"GLI2\", \"GLI3\", \"GLI1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":8,"faith_total":8,"faith_pct":100.0}}